Jean‐henri Bourhis

Q: What Schools Are Affiliated With Jean‐henri Bourhis

Jean‐henri Bourhis is affiliated with the following schools: University of Lausanne, Institute of Cancer Research, Paris-Saclay University, University of Melbourne, University of Birmingham

Jean‐henri Bourhis's AcademicInfluence.com Rankings

Jean‐henri Bourhis

Biology

#7306

World Rank

#10207

Historical Rank

Immunology

#391

World Rank

#406

Historical Rank

Biochemistry

#1001

World Rank

#1114

Historical Rank

biology Degrees

Download Badge

Biology

Jean‐henri Bourhis's Degrees

PhD Immunology Université Paris Cité
Masters Biology Université Paris Cité
Bachelors Biochemistry Université Paris Cité

Similar Degrees You Can Earn

Best Online Master's in Biology

Why Is Jean‐henri Bourhis Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jean‐henri Bourhis's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy (2007) (2668)
Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. (2004) (2629)
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. (2009) (2621)
Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data (2000) (2247)
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis (2006) (1005)
Maintenance therapy with thalidomide improves survival in patients with multiple myeloma. (2006) (662)
Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02. (2010) (656)
Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients. (2006) (613)
Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice (2014) (576)
Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis. (2015) (565)
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site. (2011) (557)
Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer. (2010) (393)
Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle. (2000) (374)
CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines. (2015) (369)
Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial. (2003) (368)
Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia--results of the prospective multicenter LALA-94 trial. (2002) (359)
Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myeloma. (2006) (354)
Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART): a phase III trial of the Trans-Tasman Radiation Oncology Group. (2010) (349)
Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma. (2008) (321)
The Advantage of FLASH Radiotherapy Confirmed in Mini-pig and Cat-cancer Patients (2018) (311)
Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial. (2012) (310)
Radiotherapy combination opportunities leveraging immunity for the next oncology practice (2017) (291)
Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): an update. (2007) (290)
Irradiation in a flash: Unique sparing of memory in mice after whole brain irradiation with dose rates above 100Gy/s. (2017) (290)
Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients. (1998) (289)
Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA (1990) (287)
Treatment of a first patient with FLASH-radiotherapy. (2019) (269)
Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group. (2013) (266)
Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Ce (2006) (263)
A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission. (2012) (258)
Nanoscale radiotherapy with hafnium oxide nanoparticles. (2012) (252)
Mechanisms of Disease: signaling of the insulin-like growth factor 1 receptor pathway—therapeutic perspectives in cancer (2007) (236)
What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis. (2017) (236)
Clinical translation of FLASH radiotherapy: Why and how? (2019) (220)
Long-term neurocognitive benefits of FLASH radiotherapy driven by reduced reactive oxygen species (2019) (219)
Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia. (2015) (214)
Randomized study of intensified anthracycline doses for induction and recombinant interleukin-2 for maintenance in patients with acute myeloid leukemia age 50 to 70 years: results of the ALFA-9801 study. (2010) (208)
Nasopharyngeal carcinomas: an update. (2003) (201)
Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis. (2017) (194)
Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study. (2002) (186)
X-rays can trigger the FLASH effect: Ultra-high dose-rate synchrotron light source prevents normal brain injury after whole brain irradiation in mice. (2018) (186)
Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies. (2004) (181)
BCR-ABL down-regulates the DNA repair protein DNA-PKcs. (2001) (178)
Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: results of a retrospective study of 386 patients. (1989) (177)
Postremission treatment of elderly patients with acute myeloid leukemia in first complete remission after intensive induction chemotherapy: results of the multicenter randomized Acute Leukemia French Association (ALFA) 9803 trial. (2007) (175)
The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis. (1999) (155)
Phase I/II study of cetuximab in combination with cisplatin or carboplatin and fluorouracil in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. (2006) (152)
Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data. (2009) (145)
Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers (2002) (138)
Influence of endothelial cells on vascular smooth muscle cells phenotype after irradiation: implication in radiation-induced vascular damages. (2006) (136)
Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trial. (2006) (136)
Quantification of Human Cytomegalovirus DNA in Bone Marrow Transplant Recipients by Real-Time PCR (2001) (134)
A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy. (2004) (133)
Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group. (2005) (131)
A randomized trial of induction docetaxel–cisplatin–5FU followed by concomitant cisplatin-RT versus concomitant cisplatin-RT in nasopharyngeal carcinoma (GORTEC 2006-02) (2017) (131)
Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy. (2007) (129)
Pravastatin Inhibits the Rho/CCN2/Extracellular Matrix Cascade in Human Fibrosis Explants and Improves Radiation-Induced Intestinal Fibrosis in Rats (2007) (127)
Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma (2001) (125)
Expression of a human multidrug resistance gene in ovarian carcinomas. (1989) (124)
Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation (2003) (124)
Individual patients' data meta-analyses in head and neck cancer (2007) (123)
Correlation of MDR1 gene expression with chemotherapy in neuroblastoma. (1989) (119)
Myeloid and lymphoid chimerism after T-cell-depleted bone marrow transplantation: evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA. (1992) (117)
Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma. (1991) (115)
Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: A report of the french registry on autologous transplantation in multiple myeloma (1995) (114)
Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromes (2006) (114)
Clinical activity of azacitidine in patients who relapse after allogeneic stem cell transplantation for acute myeloid leukemia (2016) (113)
Inhibition of Rho kinase modulates radiation induced fibrogenic phenotype in intestinal smooth muscle cells through alteration of the cytoskeleton and connective tissue growth factor expression (2005) (111)
Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study. (2015) (108)
Tyrphostin AG 1024 modulates radiosensitivity in human breast cancer cells (2001) (107)
End points for new agents in induction chemotherapy for locally advanced head and neck cancers. (2002) (106)
Hyperfractionated or accelerated radiotherapy for head and neck cancer. (2010) (104)
Analysis of p53 serum antibodies in patients with head and neck squamous cell carcinoma. (1996) (104)
NK cells differentiated from bone marrow, cord blood and peripheral blood stem cells exhibit similar phenotype and functions (1998) (103)
High dose‐per‐pulse electron beam dosimetry — A model to correct for the ion recombination in the Advanced Markus ionization chamber (2017) (103)
High dose‐per‐pulse electron beam dosimetry: Commissioning of the Oriatron eRT6 prototype linear accelerator for preclinical use (2018) (102)
Down-regulation of BRCA1 in BCR-ABL-expressing hematopoietic cells. (2003) (102)
Clonal analysis of myelodysplastic syndrome: monosomy 7 is expressed in the myeloid lineage, but not in the lymphoid lineage as detected by fluorescent in situ hybridization. (1992) (101)
Fibrogenic signals in patients with radiation enteritis are associated with increased connective tissue growth factor expression. (2003) (101)
Autologous stem cell transplantation after first remission induction treatment in multiple myeloma. A report of the French Registry on Autologous Transplantation in Multiple Myeloma. (1995) (100)
Update of MACH-NC (Meta-Analysis of Chemotherapy in Head & Neck Cancer) database focused on concomitant chemoradiotherapy (2004) (99)
Radiotherapy with concomitant weekly docetaxel for Stages III/IV oropharynx carcinoma. Results of the 98-02 GORTEC Phase II trial. (2004) (98)
Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update. (2019) (97)
Induction Chemotherapy Followed by Cetuximab Radiotherapy Is Not Superior to Concurrent Chemoradiotherapy for Head and Neck Carcinomas: Results of the GORTEC 2007-02 Phase III Randomized Trial. (2018) (97)
Enhancement of radiation response in p53-deficient cancer cells by the Aurora-B kinase inhibitor AZD1152 (2007) (96)
Influence of Nucleoshuttling of the ATM Protein in the Healthy Tissues Response to Radiation Therapy: Toward a Molecular Classification of Human Radiosensitivity. (2016) (96)
A randomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinoma. (2000) (92)
Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion (2005) (92)
Hypofractionated FLASH-RT as an Effective Treatment against Glioblastoma that Reduces Neurocognitive Side Effects in Mice (2020) (90)
Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantation. (2015) (90)
Long-term outcomes after reduced-intensity conditioning allogeneic stem cell transplantation for low-grade lymphoma: a survey by the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC). (2007) (88)
Salvage surgery after concomitant chemoradiation in head and neck squamous cell carcinomas—Stratification for postsalvage survival (2009) (88)
High dose‐per‐pulse electron beam dosimetry: Usability and dose‐rate independence of EBT3 Gafchromic films (2017) (87)
A pre-clinical assessment of an atlas-based automatic segmentation tool for the head and neck. (2009) (85)
Environmental, genetic, and molecular features of prostate cancer. (2004) (84)
Update of MACH-NC (Meta-Analysis of Chemotherapy in Head & Neck Cancer) database focused on concomitant chemoradiotherapy. (2004) (84)
Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie Cellulaire (2010) (82)
Salvage surgery after failure of very accelerated radiotherapy in advanced head-and-neck squamous cell carcinoma. (2005) (82)
Effect of Ku80 depletion on the preintegrative steps of HIV-1 replication in human cells. (2002) (79)
Effect of priming with granulocyte–macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group (2007) (77)
Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma for patients <or=50 years old in first complete remission: results of the EORTC ALL-3 trial. (2004) (76)
Induction of CTGF by TGF-beta1 in normal and radiation enteritis human smooth muscle cells: Smad/Rho balance and therapeutic perspectives. (2005) (76)
Gene Expression Profile in Human Late Radiation Enteritis Obtained by High-Density cDNA Array Hybridization (2004) (76)
Mesenchymal cells generated from patients with myelodysplastic syndromes are devoid of chromosomal clonal markers and support short- and long-term hematopoiesis in vitro (2005) (76)
Botulinum toxin for radiation-induced facial pain and trismus (2008) (75)
Phase I study of lapatinib in combination with chemoradiation in patients with locally advanced squamous cell carcinoma of the head and neck. (2009) (75)
Rescue procedure for an electrical storm using robotic non-invasive cardiac radio-ablation. (2018) (75)
Postoperative Adjuvant Lapatinib and Concurrent Chemoradiotherapy Followed by Maintenance Lapatinib Monotherapy in High-Risk Patients With Resected Squamous Cell Carcinoma of the Head and Neck: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study. (2015) (74)
Successful mitigation of delayed intestinal radiation injury using pravastatin is not associated with acute injury improvement or tumor protection. (2007) (73)
Prospective randomized comparison of single-dose versus hyperfractionated total-body irradiation in patients with hematologic malignancies. (2000) (72)
Radiation therapy for head and neck cancers in the elderly. (1990) (72)
Randomized phase III trial (GORTEC 98-03) comparing re-irradiation plus chemotherapy versus methotrexate in patients with recurrent or a second primary head and neck squamous cell carcinoma, treated with a palliative intent. (2011) (71)
Mixed treatment comparison meta-analysis of altered fractionated radiotherapy and chemotherapy in head and neck cancer. (2011) (70)
Chemotherapy as an adjunct to radiotherapy in locally advanced nasopharyngeal carcinoma. (2006) (70)
Enhancement of radiation response by inhibition of Aurora-A kinase using siRNA or a selective Aurora kinase inhibitor PHA680632 in p53-deficient cancer cells (2007) (70)
Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experience (2005) (69)
Randomized phase III trial comparing induction chemotherapy using cisplatin (P) fluorouracil (F) with or without docetaxel (T) for organ preservation in hypopharynx and larynx cancer. Preliminary results of GORTEC 2000-01. (2006) (69)
Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (2013) (68)
Enhancement of radiation response by roscovitine in human breast carcinoma in vitro and in vivo. (2003) (67)
Comparison of autologous bone marrow transplantation and peripheral blood stem cell transplantation after first remission induction treatment in multiple myeloma. (1995) (67)
Adjusting for patient selection suggests the addition of docetaxel to 5-fluorouracil–cisplatin induction therapy may offer survival benefit in squamous cell cancer of the head and neck (2004) (67)
Global gene expression profiles reveal an increase in mRNA levels of collagens, MMPs, and TIMPs in late radiation enteritis. (2004) (67)
A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from the French Bone Marrow Transplantation Society (2003) (66)
Rapid tumor cell proliferation after induction chemotherapy in oropharyngeal cancer (1994) (64)
Meta-analyses in head and neck squamous cell carcinoma. What is the role of chemotherapy? (1999) (64)
Radiosensitization by Chir-124, a selective Chk1 inhibitor: Effects of p53 and cell cycle checkpoints (2009) (63)
Telomere shortening and associated chromosomal instability in peripheral blood lymphocytes of patients with Hodgkin's lymphoma prior to any treatment are predictive of second cancers. (2007) (62)
Quantified relationship between cellular radiosensitivity, DNA repair defects and chromatin relaxation: a study of 19 human tumour cell lines from different origin. (2004) (62)
Predictive assays of radiation response in patients with head and neck squamous cell carcinoma: a review of the Institute Gustave Roussy experience. (1997) (62)
Current concepts of management in radiotherapy for head and neck squamous-cell cancer. (2009) (61)
Leukemic target susceptibility to natural killer cytotoxicity: relationship with BCR-ABL expression. (2002) (60)
Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 GY in 7 weeks. (1996) (60)
Dosimetric and preparation procedures for irradiating biological models with pulsed electron beam at ultra-high dose-rate. (2019) (60)
Preliminary data of the GORTEC 2000-02 phase III trial comparing intravenous and subcutaneous administration of amifostine for head and neck tumors treated by external radiotherapy. (2002) (59)
Molecular markers predicting radiotherapy response: report and recommendations from an International Atomic Energy Agency technical meeting. (2005) (59)
Decreased DNA-PK activity in human cancer cells exhibiting hypersensitivity to low-dose irradiation (2000) (59)
Surveillance of Aspergillus galactomannan antigenemia for invasive aspergillosis by enzyme-linked immunosorbent assay in neutropenic patients treated for hematological malignancies. (2000) (58)
Novel Anti-Metastatic Action of Cidofovir Mediated by Inhibition of E6/E7, CXCR4 and Rho/ROCK Signaling in HPV+ Tumor Cells (2009) (56)
Leukemic stem cell persistence in chronic myeloid leukemia patients in deep molecular response induced by tyrosine kinase inhibitors and the impact of therapy discontinuation (2016) (56)
Commissioning of the Leksell Gamma Knife® Icon™ (2017) (56)
n-3 Polyunsaturated fatty acids decrease mucosal/epidermal reactions and enhance antitumour effect of ionising radiation with inhibition of tumour angiogenesis (2003) (56)
Cross-resistance to ionizing radiation in a murine leukemic cell line resistant to cis-dichlorodiammineplatinum(II): role of Ku autoantigen. (1999) (55)
Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire. (2008) (55)
Concomitant radiochemotherapy or accelerated radiotherapy: analysis of two randomized trials of the French Head and Neck Cancer Group (GORTEC). (2004) (55)
Treatment of the N0 neck during salvage surgery after radiotherapy of head and neck squamous cell carcinoma (2005) (54)
Multiple molecular mechanisms contribute to radiation sensitivity in mantle cell lymphoma (2003) (53)
Comparison of high-dose cytarabine and timed-sequential chemotherapy as consolidation for younger adults with AML in first remission: the ALFA-9802 study. (2011) (53)
c-Myc regulates expression of NKG2D ligands ULBP1/2/3 in AML and modulates their susceptibility to NK-mediated lysis. (2014) (53)
Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized study. (2007) (52)
Improved Outcome by Adding Concurrent Chemotherapy to Cetuximab and Radiotherapy for Locally Advanced Head and Neck Carcinomas: Results of the GORTEC 2007-01 Phase III Randomized Trial. (2018) (52)
Effect of amifostine on survival among patients treated with radiotherapy: a meta-analysis of individual patient data. (2011) (52)
Overview of the predictive value of quantitative 18 FDG PET in head and neck cancer treated with chemoradiotherapy. (2016) (52)
Antiviral agent Cidofovir decreases Epstein–Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies (2003) (51)
LBA38 Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of the GORTEC 2015-01 “PembroRad” randomized trial (2020) (51)
The Aurora B kinase inhibitor AZD1152 sensitizes cancer cells to fractionated irradiation and induces mitotic catastrophe (2009) (50)
Subcutaneous compared with intravenous administration of amifostine in patients with head and neck cancer receiving radiotherapy: final results of the GORTEC2000-02 phase III randomized trial. (2011) (50)
Maintenance Treatment with Thalidomide after Autologous Transplantation for Myeloma : First Analysis of a Prospective Randomized Study of the Intergroupe Francophone du Myelome (IFM 99 02). (2004) (50)
Prognostic value of c-myc proto-oncogene overexpression in early invasive carcinoma of the cervix. (1990) (50)
In vivo measurement of the potential doubling time by flowcytometry in oropharyngeal cancer treated by conventional radiotherapy. (1993) (50)
Comparison of unrelated cord blood and peripheral blood stem cell transplantation in adults with myelodysplastic syndrome after reduced-intensity conditioning regimen: a collaborative study from Eurocord (Cord blood Committee of Cellular Therapy & Immunobiology Working Party of EBMT) and Chronic Mal (2015) (49)
Individual patient-versus literature-based meta-analysis of survival data: time to event and event rate at a particular time can make a difference, an example based on head and neck cancer. (2001) (49)
Dependence on Phosphoinositide 3-Kinase and RAS-RAF Pathways Drive the Activity of RAF265, a Novel RAF/VEGFR2 Inhibitor, and RAD001 (Everolimus) in Combination (2010) (49)
Concurrent use of cisplatin or cetuximab with definitive radiotherapy for locally advanced head and neck squamous cell carcinomas (2014) (48)
N-myc genomic content and DNA ploidy in stage IVS neuroblastoma. (1991) (48)
p53-dependent G2 arrest associated with a decrease in cyclins A2 and B1 levels in a human carcinoma cell line (2000) (48)
The Decreased Susceptibility of Bcr/Abl Targets to NK Cell-Mediated Lysis in Response to Imatinib Mesylate Involves Modulation of NKG2D Ligands, GM1 Expression, and Synapse Formation1 (2006) (48)
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial. (2021) (48)
[18F]FDG-PET/CT metabolic parameters as useful prognostic factors in cervical cancer patients treated with chemo-radiotherapy (2016) (47)
TPExtreme randomized trial: TPEx versus Extreme regimen in 1st line recurrent/metastatic head and neck squamous cell carcinoma. (2015) (47)
Adaptive radiotherapy for head and neck cancer (2018) (46)
Coronary stenosis risk analysis following Hodgkin lymphoma radiotherapy: A study based on patient specific artery segments dose calculation. (2015) (46)
Radiotherapy-chemotherapy combinations in head and neck squamous cell carcinoma: overview of randomized trials. (1996) (46)
Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study. (2020) (46)
Transfer of Ku86 RNA antisense decreases the radioresistance of human fibroblasts (2000) (46)
Surrogate End Points for Overall Survival in Loco-Regionally Advanced Nasopharyngeal Carcinoma: An Individual Patient Data Meta-analysis (2017) (46)
A case of multicentric Castleman's disease associated with advanced systemic amyloidosis treated with chemotherapy and anti-CD20 monoclonal antibody (2003) (45)
Hepatocyte growth factor/scatter factor (HGF/SF) affects proliferation and migration of myeloid leukemic cells (1998) (44)
New techniques in radiation therapy for head and neck cancer: IMRT, CyberKnife, protons, and carbon ions. Improved effectiveness and safety? Impact on survival? (2011) (43)
Quantitative analysis of T helper 1, T helper 2, and inflammatory cytokine expression in patients after allogeneic bone marrow transplantation: relationship with the occurrence of acute graft-versus-host disease. (1997) (43)
A phase II randomized trial of pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN): First results of the GORTEC 2015-01 “PembroRad” trial. (2018) (43)
A Ku80 fragment with dominant negative activity imparts a radiosensitive phenotype to CHO-K1 cells. (2000) (43)
The radiosensitizing activity of the SMAC-mimetic, Debio 1143, is TNFα-mediated in head and neck squamous cell carcinoma. (2015) (42)
Apnea-like suppression of respiratory motion: First evaluation in radiotherapy. (2016) (42)
Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer. (2007) (41)
Conventional vs modified fractionated radiotherapy. meta-analysis of radiotherapy in head & neck squamous cell carcinoma : a meta-analysis based on individual patient data (2002) (40)
[(18)F]FDG-PET standard uptake value as a metabolic predictor of bone marrow response to radiation: impact on acute and late hematological toxicity in cervical cancer patients treated with chemoradiation therapy. (2013) (40)
Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplant R (2016) (40)
Glucagon-like peptide-2 improves both acute and late experimental radiation enteritis in the rat. (2007) (39)
Limited efficacy and tolerance of imatinib mesylate in steroid-refractory sclerodermatous chronic GVHD. (2012) (39)
IMRT or conformal radiotherapy for adjuvant treatment of retroperitoneal sarcoma? (2011) (39)
Radioprotective effect of amifostine in patients with head and neck squamous cell carcinoma. (2002) (39)
Autologous peripheral-blood progenitor-cell support following high-dosechemotherapy or chemoradiotherapy in patients with high-risk multiple myeloma. (1996) (38)
High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL) (2006) (38)
Activation of cytotoxic T-cell receptor γδ T lymphocytes in response to specific stimulation in myelodysplastic syndromes (2008) (38)
Osteopontin is upregulated by BCR-ABL. (2005) (38)
Impact of disease status and stem cell source on the results of reduced intensity conditioning transplant for Hodgkin’s lymphoma: a retrospective study from the French Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) (2013) (38)
Reirradiation in squamous cell head and neck cancer: recent developments and future directions (2007) (37)
Very accelerated radiation therapy: preliminary results in locally unresectable head and neck carcinomas. (1995) (37)
Lenalidomide as salvage treatment for multiple myeloma relapsing after allogeneic hematopoietic stem cell transplantation: a report from the French Society of Bone Marrow and Cellular Therapy (2013) (37)
Tyrosine kinase inhibitor AG1024 exerts antileukaemic effects on STI571-resistant Bcr-Abl expressing cells and decreases AKT phosphorylation (2004) (37)
Preclinical assessment of JNJ-26854165 (Serdemetan), a novel tryptamine compound with radiosensitizing activity in vitro and in tumor xenografts. (2011) (37)
Multimodal treatment and long-term outcome of patients with esthesioneuroblastoma. (2013) (36)
JC human polyomavirus is associated to chromosomal instability in peripheral blood lymphocytes of Hodgkin's lymphoma patients and poor clinical outcome. (2010) (36)
Microvascular leakage and contrast enhancement as prognostic factors for recurrence in unfavorable low-grade gliomas (2010) (36)
[Individual patient data meta-analyses in head and neck carcinoma: what have we learnt?]. (2005) (35)
Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study results. (2020) (35)
Improving the Outcome of Leukemia by Natural Killer Cell-Based Immunotherapeutic Strategies (2014) (35)
ESTRO 2012 strategy meeting: vision for radiation oncology. (2012) (35)
Baseline and treatment-induced chromosomal abnormalities in peripheral blood lymphocytes of Hodgkin's lymphoma patients. (2003) (35)
How could breast cancer molecular features contribute to locoregional treatment decision making? (2017) (35)
Human papillomavirus-negative status and c-myc gene overexpression: independent prognostic indicators of distant metastasis for early-stage invasive cervical cancers. (1992) (34)
A new method of assessing the dose-carcinogenic effect relationship in patients exposed to ionizing radiation. A concise presentation of preliminary data. (2011) (34)
Assessment and management of cutaneous reactions with amifostine administration: findings of the ethyol (amifostine) cutaneous treatment advisory panel (ECTAP). (2004) (34)
Oral cavity squamous cell carcinoma in 260 patients aged 80years or more. (2009) (33)
Radiation‐induced expression of functional Fas ligand in EBV‐positive human nasopharyngeal carcinoma cells (2000) (33)
New approaches to enhance chemotherapy in SCCHN. (2005) (33)
Cyclooxygenase-2 inhibitor NS398 enhances antitumor effect of irradiation on hormone refractory human prostate carcinoma cells. (2003) (33)
Avelumab-cetuximab-radiotherapy versus standards of care in locally advanced squamous-cell carcinoma of the head and neck: The safety phase of a randomised phase III trial GORTEC 2017-01 (REACH). (2020) (33)
Altered fractionated radiotherapy in the management of head and neck carcinomas: advantages and limitations (2004) (33)
Advances in radiotherapy of head and neck cancers (2010) (32)
High-dose chemotherapy with etoposide, cyclophosphamide and escalating dose of carboplatin followed by autologous bone marrow transplantation in cancer patients. A pilot study. (1993) (32)
Cost effectiveness of day 5 G-CSF (Lenograstim®) administration after PBSC transplantation: results of a SFGM-TC randomised trial (2005) (32)
Highly sensitive polymerase chain reaction methods show the frequent survival of residual recipient multipotent progenitors after non−T-cell−depleted bone marrow transplantation (1994) (31)
Combined radiation sensitizing and anti-angiogenic effects of ionizing radiation and the protease inhibitor ritonavir in a head and neck carcinoma model. (2005) (31)
Chromosome 11q13 gene amplifications in oral and oropharyngeal carcinomas: no correlation with subclinical lymph node invasion and disease recurrence. (1997) (31)
Impact of age on treatment effect in locally advanced head and neck cancer (HNC): Two individual patient data meta-analyses. (2006) (31)
Nasopharyngeal carcinoma and therapeutic management: the place of chemotherapy. (2006) (31)
Ex vivo expansion of megakaryocyte precursor cells in autologous stem cell transplantation for relapsed malignant lymphoma (2004) (31)
Related donor transplants: has posttransplantation cyclophosphamide nullified the detrimental effect of HLA mismatch? (2018) (30)
Very accelerated versus conventional radiotherapy in HNSCC: Results of the GORTEC 94-02 randomized trial (2000) (30)
Meta-analysis of chemotherapy in head and neck cancer: individual patient data vs literature data. (1995) (29)
Impact of antithymocyte globulin doses in reduced intensity conditioning before allogeneic transplantation from matched sibling donor for patients with acute myeloid leukemia: a report from the acute leukemia working party of European group of Bone Marrow Transplantation (2018) (29)
Phase I study of cetuximab in combination with cisplatin or carboplatin and 5-fluorouracil (5-FU) in patients (pts) with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN). (2004) (29)
Clonality in myelodysplastic syndromes. (1994) (29)
The c-myc proto-oncogene in invasive carcinomas of the uterine cervix: clinical relevance of overexpression in early stages of the cancer. (1990) (29)
Radiotherapy in head and neck cancer in the elderly: a challenge. (2000) (28)
Efficacy of Recombinant Human Interleukin 7 in a Patient With Severe Lymphopenia-Related Progressive Multifocal Leukoencephalopathy (2014) (28)
Commissioning of an ultra-high dose rate pulsed electron beam medical LINAC for FLASH RT pre-clinical animal experiments and future clinical human protocols. (2021) (28)
Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2021) (28)
Altered natural killer cell differentiation in CD34+ progenitors from Chronic Myeloid Leukemia patients (2000) (28)
Hypofractionated radiotherapy in pancreatic cancer: Lessons from the past in the era of stereotactic body radiation therapy. (2016) (27)
Chromosomal Minimal Critical Regions in Therapy-Related Leukemia Appear Different from Those of De Novo Leukemia by High-Resolution aCGH (2011) (27)
Caspase independence of radio-induced cell death (2006) (27)
FLASH radiotherapy International Workshop. (2019) (27)
Interfractional set-up errors evaluation by daily electronic portal imaging of IMRT in head and neck cancer patients (2009) (27)
The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMT (2019) (27)
Accelerated radiotherapy and concomitant high dose chemotherapy in non resectable stage IV locally advanced HNSCC: results of a GORTEC randomized trial. (2011) (27)
Phase III study of tirapazamine, cisplatin and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (2008) (27)
Early evaluation of natural killer activity in post-transplant acute myeloid leukemia patients (2010) (27)
BMS-690514, a VEGFR and EGFR tyrosine kinase inhibitor, shows anti-tumoural activity on non-small-cell lung cancer xenografts and induces sequence-dependent synergistic effect with radiation (2010) (26)
Approach to oligometastatic disease in head and neck cancer, on behalf of the GORTEC. (2018) (26)
Induction docetaxel platinum 5-FU (TPF) followed by cetuximab-radiotherapy (cetux-RT) versus concurrent chemo-radiotherapy (CT/RT) in patients with N2b/c-N3 non operated stage III-IV squamous cell cancer of the head and neck (SCCHN): Results of the GORTEC 2007-02 phase III randomized trial. (2016) (26)
Chromosomal aberrations induced by chemotherapy and radiotherapy in lymphocytes from patients with breast carcinoma. (2002) (25)
50-Gy Stereotactic Body Radiation Therapy to the Dominant Intraprostatic Nodule: Results From a Phase 1a/b Trial. (2019) (25)
Cellular Composition and Contribution of Tertiary Lymphoid Structures to Tumor Immune Infiltration and Modulation by Radiation Therapy (2018) (24)
Cytogenetic assessment of heterogeneous radiation doses in cancer patients treated with fractionated radiotherapy. (2010) (24)
PROTECTIVE EFFECT OF OESTROGEN IN PANCREATIC CANCER (1987) (24)
Chemo-radiotherapy in head and neck cancer. (2006) (23)
The efficacy and toxicity of EGFR in the settings of radiotherapy: Focus on published clinical trials. (2008) (23)
Implications of learning effects for hospital costs of new health technologies: The case of intensity modulated radiation therapy (2007) (23)
Telomere shortening: a new prognostic factor for cardiovascular disease post-radiation exposure. (2015) (23)
Proton therapy for head and neck squamous cell carcinomas: A review of the physical and clinical challenges. (2020) (23)
Prevention of Menstruation with Leuprorelin (GnRH Agonist) in Women Undergoing Myelosuppressive Chemotherapy or Radiochemotherapy for Hematological Malignancies: a Pilot Study (2001) (23)
Pravastatin Reverses Established Radiation-Induced Cutaneous and Subcutaneous Fibrosis in Patients With Head and Neck Cancer: Results of the Biology-Driven Phase 2 Clinical Trial Pravacur. (2019) (22)
Randomized Comparison of Standard Induction with Daunorubicin (DNR) for 3 Days vs Idarubicin (IDA) for 3 or 4 Days in AML pts Aged 50 to 70 and of Maintenance with Interleukin 2. Final Analysis of the ALFA 9801 Study. (2007) (22)
Evaluation of infectious complications after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide following reduced-intensity and myeloablative conditioning: a study on behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-T (2016) (22)
Inhibition of BCL-2 in small cell lung cancer cell lines with oblimersen, an antisense BCL-2 oligodeoxynucleotide (ODN): in vitro and in vivo enhancement of radiation response. (2010) (22)
Prognostic significance of recurring chromosomal abnormalities in transplanted patients with acute myeloid leukemia (2019) (22)
A Personalized Approach to Guide Allogeneic Stem Cell Transplantation in Younger Adults with Acute Myeloid Leukemia. (2020) (22)
Surrogate End Points for Overall Survival in Loco-Regionally Advanced Nasopharyngeal Carcinoma: An Individual Patient Data Meta-analysis. (2017) (21)
New trends in radiotherapy for head and neck cancer. (2005) (21)
Differential effect triggered by a heparan mimetic of the RGTA family preventing oral mucositis without tumor protection. (2009) (21)
Early side effects of three-dimensional conformal external beam accelerated partial breast irradiation to a total dose of 40 Gy in one week (a phase II trial). (2011) (21)
Role of chemotherapy in 5000 patients with head and neck cancer treated by curative surgery: A subgroup analysis of the meta-analysis of chemotherapy in head and neck cancer. (2019) (21)
Imaging in Hepatic Veno-occlusive Disease/Sinusoidal Obstruction Syndrome. (2020) (20)
Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: An analysis from the acute leukemia working party of the EBMT (2017) (20)
Antiviral approaches for cancers related to Epstein-Barr virus and human papillomavirus. (2001) (20)
Prognostic value of MDR1 gene expression in neuroblastoma: results of a multivariate analysis. (1994) (20)
Re-irradiation combined with chemotherapy after salvage surgery in head and neck carcinoma: A randomized trial from the GETTEC and GORTEC groups. (2006) (20)
Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple Myeloma. (2018) (19)
Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis. (2021) (19)
TPExtreme randomized trial: Quality of Life (QoL) and survival according to second-line treatments in patients with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC). (2020) (18)
Clinical efficacy of second generation tyrosine kinase inhibitor and 5-azacytidine combination in chronic myelogenous leukaemia in myeloid blast crisis. (2013) (18)
Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4. (1989) (18)
Stereotactic Radiotherapy for the Management of Refractory Ventricular Tachycardia: Promise and Future Directions (2020) (18)
Avelumab-cetuximab-radiotherapy (RT) versus standards of care (SoC) in locally advanced squamous cell carcinoma of the head and neck (SCCHN): Safety phase of the randomized trial GORTEC 2017-01 (REACH). (2018) (17)
Comparison of Dynamic International Prognostic Scoring System and MYelofibrosis SECondary to PV and ET Prognostic Model for Prediction of Outcome in Polycythemia Vera and Essential Thrombocythemia Myelofibrosis after Allogeneic Stem Cell Transplantation. (2019) (17)
Modern intensity-modulated radiotherapy with image guidance allows low toxicity rates and good local control in chemoradiotherapy for anal cancer patients (2018) (17)
Sensitivity to Radiation and Alkylating Agent of Peripheral Lymphocytes and Fibroblasts in a Hoyeraal-Hreidarsson Syndrome Patient (2003) (17)
Relationship between pneumonitis induced by immune checkpoint inhibitors and the underlying parenchymal status: a retrospective study (2020) (17)
Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia (2018) (17)
PET-based prognostic survival model after radiotherapy for head and neck cancer (2018) (17)
A PET-based nomogram for oropharyngeal cancers. (2017) (17)
Distant Metastasis of Undifferentiated Carcinoma of Nasopharyngeal Type (2008) (17)
Retreatment of recurrent head and neck cancer in a previously irradiated field. (2012) (17)
Clinical significance of multiple drug resistance in human cancers. (1990) (16)
Monitoring translocations by M-FISH and three-color FISH painting techniques: a study of two radiotherapy patients. (2007) (16)
Similar outcome of allogeneic stem cell transplantation after myeloablative and sequential conditioning regimen in patients with refractory or relapsed acute myeloid leukemia: A study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (2018) (16)
Long‐term study of chimaerism in bone marrow transplantation recipients for severe aplastic anaemia (1989) (16)
Discrepancies between selected Pareto optimal plans and final deliverable plans in radiotherapy multi-criteria optimization. (2016) (16)
Accelerated versus Conventional Radiotherapy with Concomitant Chemotherapy in Locally Advanced Head and Neck Carcinomas: Results of a Phase III Randomized Trial (2008) (16)
miR-181a modulates acute myeloid leukemia susceptibility to natural killer cells (2015) (16)
Novel inverse planning optimization algorithm for robotic radiosurgery: First clinical implementation and dosimetric evaluation. (2019) (16)
Detection of recipient cells after non T-cell depleted bone marrow transplantation for leukemia by PCR amplification of minisatellites or of a Y chromosome marker has a different prognostic value. (1994) (15)
Successful pregnancy after allogeneic bone marrow transplantation following conditioning including a 10-Gy single exposure total body irradiation. (1996) (15)
Preliminary results of the GORTEC 96-01 randomized trial, comparing very accelerated radiotherapy versus concomitant radio-chemotherapy for locally inoperable HNSCC (2001) (15)
(18F)-FDG PET/CT parameters to predict survival and recurrence in patients with locally advanced cervical cancer treated with chemoradiotherapy. (2018) (15)
Should we include SPECT lung perfusion in radiotherapy treatment plans of thoracic targets? Evidences from the literature. (2016) (15)
Cooperative effect of roscovitine and irradiation targets angiogenesis and induces vascular destabilization in human breast carcinoma (2009) (15)
Burkitt's acute lymphocytic leukemia (L3ALL) in adults. (2001) (15)
Difference in performance between 3D and 4D CBCT for lung imaging: a dose and image quality analysis. (2016) (15)
Status of accelerated fractionation radiotherapy in head and neck squamous cell carcinomas. (1997) (15)
Escalating high-dose carboplatin and autologous bone marrow transplantation in solid tumors. (1993) (15)
Avelumab and cetuximab as a therapeutic combination: An overview of scientific rationale and current clinical trials in cancer. (2021) (15)
A retrospective, matched paired analysis comparing bendamustine containing BeEAM versus BEAM conditioning regimen: results from a single center experience (2018) (15)
Therapy‐related myelodysplasia and/or acute myeloid leukaemia after autologous haematopoietic progenitor cell transplantation in a prospective single centre cohort of 221 patients (2003) (15)
Molecular profiling of uterine cervix carcinoma: an overview with a special focus on rationally designed target-based anticancer agents (2008) (15)
Concurrent cisplatin and Dose escalation with Intensity-modulated radiotherapy (IMRT) versus conventional radiotherapy for locally advanced head and neck squamous cell carcinomas (HNSCC): GORTEC 2004-01 randomized phase III trial. (2020) (15)
Gallium scan in the evaluation of post chemotherapy mediastinal residual masses of aggressive non-Hodgkin's lymphoma. (1999) (14)
Comparison of dose contribution to normal pelvic tissues among conventional, conformal and intensity-modulated radiotherapy techniques in prostate cancer (2008) (14)
Meta-analysis of chemotherapy in nasopharyngeal carcinoma (MAC-NPC): An update on 4,798 patients. (2014) (14)
Mobilization of peripheral blood progenitor cells after DHAP regimen with or without rituximab: A large multicenter comparative study in patients with malignant lymphoma (2007) (14)
Bio-radiation dermatitis: the need of a new grading: in regard to Bernier et al: Ann Oncol 2011; 22(10): 2191-2200. (2013) (14)
Meta-analysis of conventional versus altered fractionated radiotherapy in head and neck squamous cell carcinoma (HNSCC): Final analysis (2004) (14)
Correlation between p53 gene expression and tumor-cell proliferation in oropharyngeal cancer. (1994) (14)
Reduction of Respiratory Motion During PET/CT by Pulsatile-Flow Ventilation: A First Clinical Evaluation (2016) (14)
Duplication of the Ph-chromosome as a possible mechanism of resistance to imatinib mesylate in patients with chronic myelogenous leukemia. (2005) (13)
A randomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinoma (2001) (13)
Definitive radiotherapy for squamous cell carcinoma of the pyriform sinus. (2012) (13)
Serum interleukin-12 levels in patients undergoing allogeneic or autologous bone marrow transplantation. (1996) (13)
Cetuximab-radiotherapy versus cetuximab-radiotherapy plus concurrent chemotherapy in patients with N0-N2a squamous cell carcinoma of the head and neck (SCCHN): Results of the GORTEC 2007-01 phase III randomized trial. (2016) (13)
Allogeneic stem cell transplantation in second complete remission for core binding factor acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2019) (13)
Comparative outcomes of myeloablative and reduced‐intensity conditioning allogeneic hematopoietic cell transplantation for therapy‐related acute myeloid leukemia with prior solid tumor: A report from the acute leukemia working party of the European society for blood and bone marrow transplantation (2019) (12)
Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients (2020) (12)
TAT-RasGAP317–326 Enhances Radiosensitivity of Human Carcinoma Cell Lines In Vitro and In Vivo through Promotion of Delayed Mitotic Cell Death (2017) (12)
Monitoring antibiotic-resistant enterobacteria faecal levels is helpful in predicting antibiotic susceptibility of bacteraemia isolates in patients with haematological malignancies. (2015) (12)
Impact of the type of anthracycline and of stem cell transplantation in younger patients with acute myeloid leukaemia: Long‐term follow up of a phase III study (2020) (12)
Randomized trial comparing two methods of re-irradiation after salvage surgery in head and neck squamous cell carcinoma: Once daily split-course radiotherapy with concomitant chemotherapy or twice daily radiotherapy with cetuximab. (2018) (12)
Metabolic Tumor Volume and Total Lesion Glycolysis in Oropharyngeal Cancer Treated With Definitive Radiotherapy: Which Threshold Is the Best Predictor of Local Control? (2017) (12)
Cancers des voies aérodigestives supérieures (VADS) localement avancés : recommandations d’un panel d’experts et de perspectives pour l’utilisation du schéma TPF (docétaxel, cisplatine, 5-fluoro-uracile) en induction (2009) (12)
High numbers of mobilized CD34+ cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMT (2015) (12)
Prolonged Apnea Supported by High-Frequency Noninvasive Ventilation: A Pilot Study. (2017) (12)
Clofarabine versus fludarabine‐based reduced‐intensity conditioning regimen prior to allogeneic transplantation in adults with AML/MDS (2016) (12)
Multicenter Randomized Double-Blind, Placebo-Controlled Trial GORTEC (Groupe Oncologie Radiotherapie Tete et Cou) 2009-01 Evaluating the Effect of the Regenerating Agent on Radiodermatitis of Head and Neck Cancer Patients. (2017) (11)
Phase II Trial of Irinotecan (CPT-11) in Relapsed or Refractory Non-Hodgki n's Lymphomas (2003) (11)
The impact of anti-thymocyte globulin on the outcomes of Patients with AML with or without measurable residual disease at the time of allogeneic hematopoietic cell transplantation (2019) (11)
Squamous cell carcinoma of the larynx with subglottic extension: is larynx preservation possible? (2013) (11)
[Late effects of radiations on mature and growing bone]. (1997) (11)
Chest-MRI under pulsatile flow ventilation: A new promising technique (2017) (11)
Efficacy and safety of helical tomotherapy with daily image guidance in anal canal cancer patients (2016) (11)
Younger donor’s age and upfront tandem are two independent prognostic factors for survival in multiple myeloma patients treated by tandem autologous-allogeneic stem cell transplantation: a retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) (2012) (10)
Predictive classifier for intensive treatment of head and neck cancer (2020) (10)
Inhibition of the human allogeneic mixed lymphocyte response by cyclosporin A: relationship with the IL-12 pathway. (1996) (10)
Allogeneic hematopoietic cell transplantation in acute myeloid leukemia with normal karyotype and isolated Nucleophosmin-1 (NPM1) mutation: outcome strongly correlates with disease status (2016) (10)
Hyperfractionated and/or accelerated radiotherapy versus conventional radiotherapy for head and neck cancer (2000) (10)
Altered IFNgamma signaling and preserved susceptibility to activated natural killer cell-mediated lysis of BCR/ABL targets. (2005) (10)
Anti-Ly6G binding and trafficking mediate positive neutrophil selection to unleash the anti-tumor efficacy of radiation therapy (2021) (10)
Engraftment of CD34+ peripheral blood progenitor cells into multiple myeloma patients following total body irradiation. (1995) (10)
Results of 2 meta-analyses on the role of chemotherapy (CT) in head and neck squamous cell carcinoma (HNSCC) (1998) (10)
Severe acute respiratory syndrome coronavirus 2 vaccination for patients with solid cancer: Review and point of view of a French oncology intergroup (GCO, TNCD, UNICANCER) (2021) (10)
Impact of antithymocyte globulin on outcomes of allogeneic hematopoietic cell transplantation with TBI. (2019) (10)
Enterocytozoon bieneusi Microsporidiosis in Stem Cell Transplant Recipients Treated with Fumagillin (2017) (10)
Improving safety in radiotherapy: the implementation of the Global Risk Analysis method. (2014) (10)
High Z nanoparticles and radiotherapy: a critical view. (2019) (10)
High versus low dose irradiation for tumor immune reprogramming. (2020) (10)
Stem cell transplantation from a haploidentical donor versus a genoidentical sister for adult male patients with acute myelogenous leukemia in first remission: A retrospective study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation (2019) (9)
A phase I trial combining oral cisplatin (CP Ethypharm) with radiotherapy in patients with locally advanced head and neck squamous cell carcinoma. (2011) (9)
P73 Oral cavity squamous cell carcinoma in 260 patients aged 80 years or more (2009) (9)
Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignancies (2017) (9)
Cidofovir Administered with Radiation Displays an Antiangiogenic Effect Mediated by E6 Inhibition and Subsequent TP53-Dependent VEGF Repression in HPV18+ Cell Lines (2006) (9)
Flap Delineation Guidelines in Postoperative Head and Neck Radiation Therapy for head and neck cancers. (2020) (9)
Very accelerated radiotherapy or concurrent chemoradiotherapy for N3 head and neck squamous cell carcinoma: Pooled analysis of two GORTEC randomized trials. (2017) (9)
[Normal tissue tolerance to external beam radiation therapy: larynx and pharynx]. (2010) (9)
Germline ATG2B/GSKIP-containing 14q32 duplication predisposes to early clonal hematopoiesis leading to myeloid neoplasms (2021) (9)
[The cost of intensity modulated radiation therapy in head and neck cancers: results of the 2002 STIC study]. (2006) (8)
Phase I trial of oral etoposide in combination with radiotherapy in head and neck squamous cell carcinoma - GORTEC 2004–02 (2013) (8)
Network-meta-analysis of chemotherapy in nasopharyngeal carcinoma (MAC-NPC): An update on 8,221 patients. (2020) (8)
Outcome of treatment after first relapse in younger adults with acute myeloid leukemia initially treated by the ALFA-9802 trial. (2012) (8)
Cancer de l’oropharynx (2010) (8)
Parvovirus B19 associated neutropenia. Treatment with Rh G-CSF. (1997) (8)
Tumor-infiltrating lymphocytes in triple-negative breast cancer: a biomarker for use beyond prognosis? (2015) (8)
Graft-Versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation (2021) (8)
Allogeneic vs autologous stem cell transplantation according to cytogenetic features in AML patients (pts) <= 45 yrs old in first CR: Results of the EORTC-GIMEMA AML-10 trial (2001) (8)
High‐dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL‐GITMO (2018) (8)
[Larynx preservation: nonsurgical approaches]. (2004) (8)
The olivacine S16020 enhances the antitumor effect of ionizing radiation without increasing radio-induced mucositis. (2001) (8)
Difference in performance between 3D and 4D CBCT for lung imaging: a dose and image quality analysis (2016) (8)
Helical Tomotherapy for the Treatment of Anal Canal Cancer: A Dosimetric Comparison with 3D Conformal Radiotherapy (2015) (8)
Stereotactic body radiotherapy with helical TomoTherapy for medically inoperable early stage primary and second-primary non-small-cell lung neoplasm: 1-year outcome and toxicity analysis. (2015) (8)
Optimization of Alanine Measurements for Fast and Accurate Dosimetry in FLASH Radiation Therapy (2020) (8)
Impact of respiratory-correlated CT sorting algorithms on the choice of margin definition for free-breathing lung radiotherapy treatments. (2016) (8)
TAXANE-CISPLATIN-5FU AS INDUCTION CHEMOTHERAPY IN LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA: AN INDIVIDUAL PATIENT DATA META-ANALYSIS OF THE MACH-NC GROUP (2011) (8)
Detection of chimerism in subpopulations of cells by fluorescence in situ hybridization and immunofluorescent staining of cell surface antigens. (1994) (8)
Phase I Trial of Debio 1143, an Antagonist of Inhibitor of Apoptosis Proteins, Combined with Cisplatin Chemoradiotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck (2020) (8)
Subcutaneous (SbQ) Versus Intravenous (IV) Administration of Amifostine for Head and Neck (HN) Cancer Patients Receiving Radiotherapy (RT): Preliminary Results of the GORTEC 2000–02 Randomized Trial (2005) (8)
Skin ulcers related to chronic graft‐versus‐host disease: clinical findings and associated morbidity (2014) (8)
LUX head and neck 2: A randomized, double-blind, placebo-controlled, phase III study of afatinib as adjuvant therapy after chemoradiation in primarily unresected, clinically high-risk, head and neck cancer patients. (2012) (8)
Scoring system for clinically significant CMV infection in seropositive recipients following allogenic hematopoietic cell transplant: an SFGM-TC study (2020) (7)
Characteristics of very high-energy electron beams for the irradiation of deep-seated targets. (2021) (7)
Influence of alternative donor type on early survival after hematopoietic stem cell transplantation for acute myeloid leukemia lacking a sibling donor (2019) (7)
SP-010: Update of the meta-analysis of chemotherapy in head and neck cancer (MACH-NC) (2017) (7)
[Cutaneous localization of multiple myeloma on the tract of a central venous catheter]. (2002) (7)
Oral Cavity, Pharynx, and Larynx Cancer (2006) (7)
OC-003: What is the best treatment in nasopharyngeal carcinoma? An individual patient data network meta-analysis (2015) (7)
[Concomitant chemoradiation in patients with cervix cancer]. (2005) (7)
[Indications and follow-up for autologous hematopoietic stem cell transplantation in autoimmune and autoinflammatory diseases: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. (2017) (7)
Effect of Priming with Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Younger Adults with Newly Diagnosed Acute Myeloid Leukemia (AML): A Trial by the Acute Leukemia French Association (ALFA) Group. (2005) (7)
Antilymphocyte globulin for matched sibling donor transplantation in patients with myelofibrosis (2019) (7)
Radiation-induced cell cycle delay measured in two mouse tumors in vivo using bromodeoxyuridine. (1994) (7)
A treatment planning comparison of contemporary photon-based radiation techniques for breast cancer (2018) (6)
Enhancement of IUdR Radiosensitization by Low-Energy Photons Results from Increased and Persistent DNA Damage (2017) (6)
Scoring System Based on Post-Transplant Complications in Patients after Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Study from the SFGM-TC. (2019) (6)
LBA39 3-years follow-up of double-blind randomized phase II comparing concurrent high-dose cisplatin chemo-radiation plus xevinapant or placebo in high-risk patients with locally advanced squamous cell carcinoma of the head and neck (2020) (6)
Higher Doses of Antithymocyte Globulin (ATG) Increase the Risk of Relapse in Acute Myeloid Leukemia (AML) Patients Undergoing Matched Related Donor Allogeneic Transplantation in First Complete Remission (CR1): An Analysis from the Acute Leukemia Working Party of EBMT (2014) (6)
In air and in vivo measurement of the leaf open time in tomotherapy using the on-board detector pulse-by-pulse data. (2019) (6)
Interleukin-2 may enhance or inhibit antibody production by B cells depending on intracellular cAMP concentrations. (1992) (6)
Poster: Clinical track: Treatment preparation and deliveryPO-0799: Normal brain, neural stem cells and glioblastoma responses to FLASH radiotherapy (2015) (6)
Repeated Dosing Of Anti-KIR (IPH2101) As Maintenance Therapy In Ederly Patients With Acute Myeloid Leukemia (2013) (6)
914MO Standard versus fractionated high dose cisplatin concomitant with radiotherapy in locally advanced head & neck squamous cell cancer (LA-HNSCC): Results of the GORTEC 2015-02 CisFRad randomized trial (2020) (6)
Long-term Outcome and Late Side Effects in Endometrial Cancer Patients Treated with Surgery and Postoperative Radiation Therapy (2014) (6)
Relapse from a stage IV-S neuroblastoma and N-myc amplification. (1989) (6)
Modified fractionated radiotherapy in head and neck squamous cell carcinoma (HNSCC) & re-irradiation in recurrent head and neck carcinomas. (2003) (6)
Expression of CD94 by ex vivo-differentiated NK cells correlates with the in vitro and in vivo acquisition of cytotoxic features (2017) (6)
[Hopes of high dose-rate radiotherapy]. (2017) (6)
Combining immunotherapy and radiotherapy in head and neck squamous cell cancers: which perspectives? (2020) (6)
Effect of immune modulation in relapsed peripheral T-cell lymphomas after post-allogeneic stem cell transplantation: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) (2016) (6)
Expression of MDR1 and GST pi genes in 35 advanced neuroblastomas. (1991) (5)
Introducing the BECT (biologically enhanced cytotoxic treatment) concept in cancer treatment. (2005) (5)
Split-course hypofractionated radiotherapy for aged and frail patients with head and neck cancers. A retrospective study of 75 cases. (2020) (5)
Donor Lymphocyte Infusions After Allogeneic Transplantation: A Single-Center Experience. (2019) (5)
[Neck dissection following chemoradiation for node positive head and neck carcinomas]. (2009) (5)
Atlas-based automatic segmentation (ABAS) of head and neck (H&N) structures in conformal radiotherapy (CRT): Atlas development and preliminary results in clinical context (2007) (5)
Protein-losing gastropathy associated with cytomegalovirus: a rare and late complication of allogeneic bone marrow transplantation. (1996) (5)
Benefits of chemotherapy in head and neck cancer (2000) (5)
Radiotherapy options after breast-conserving surgery: how can selection of patients be refined? (2013) (5)
Early-stage Favourable Anal Cancer: A Retrospective Analysis of Clinical Outcomes of a Moderately Low Dose Elective Nodal Intensity-modulated Radiotherapy Schedule. (2017) (5)
Abscopal effect in a patient with malignant pleural mesothelioma treated with palliative radiotherapy and pembrolizumab (2021) (5)
[Results of definitive radiotherapy for squamous cell carcinomas of the larynx patients with subglottic extension]. (2014) (5)
Medication non‐adherence after allogeneic hematopoietic cell transplantation in adult and pediatric recipients: a cross sectional study conducted by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (2020) (5)
Impact of p16 expression on induction taxotere-cisplatin-5 FU (TPF) followed by cetuximab-radiotherapy in N2b-N3 head and neck squamous cell carcinoma (HNSCC): Results of GORTEC 2007-02 phase III randomized trial. (2017) (5)
First-line treatment patterns for recurrent and/or metastatic head and neck cancer (R/M HNC) in Europe. (2010) (5)
Establishment and Characterization of a Reliable Xenograft Model of Hodgkin Lymphoma Suitable for the Study of Tumor Origin and the Design of New Therapies (2018) (5)
OC-0039: Unique sparing of spatial memory in mice after whole brain irradiation with dose rates above 100Gy/s (2017) (5)
Feasibility of radiotherapy or chemoradiotherapy after taxane-based induction chemotherapy for nonoperated locally advanced head and neck squamous cell carcinomas (2014) (5)
OC-004: A randomized trial of concomitant cisplatin-RT +/- induction TPF in locally advanced nasopharyngeal carcinomas (2015) (5)
[Gene transfer and radiotherapy]. (1996) (5)
Dose escalation of radiotherapy (RT) for locally advanced head and neck carcinomas treated with concomitant chemotherapy (CT) and RT: Results of the GORTEC 2004-01 randomized trial. (2017) (5)
Clofarabine/busulfan-based reduced intensity conditioning regimens provides very good survivals in acute myeloid leukemia patients in complete remission at transplant: a retrospective study on behalf of the SFGM-TC (2018) (5)
Percussion assisted radiation therapy in Hodgkin lymphoma allows a marked reduction in heart dose. (2020) (5)
117 : Meta-Analysis of Amifostine in Radiotherapy (MAART): Preliminary Analysis of 11 Randomized Clinical Trials Including 1,014 Patients (2006) (5)
Determination of the effective dose delivered by image guided radiotherapy in head & neck and breast treatments. (2018) (5)
[Transfer of allogeneic stem cell transplant recipients to the intensive care unit: Guidelines from the Francophone society of marrow transplantation and cellular therapy (SFGM-TC)]. (2016) (5)
[Expression of P-glycoprotein 170 (GP 170) and drug resistance in human cancers]. (1990) (4)
Dosimetry of ultra high dose rate irradiation for studies on the biological effect induced in normal brain and GBM (2016) (4)
Reply to Penack et al. and Wu (2004) (4)
Highly sensitive polymerase chain reaction methods show the frequent survival of residual recipient multipotent progenitors after non-T-cell-depleted bone marrow transplantation. (1994) (4)
Which AML Subsets Benefit from Leukemic Cell Priming during Chemotherapy? Long-Term Analysis of the ALFA-9802 GM-CSF Study (2008) (4)
Serum 2-Hydroxyglutarate Level Can Predict IDH2 Mutation in Myeloid Sarcoma (2015) (4)
What is the most effective treatment for head and neck squamous cell carcinoma? An individual patient data network meta-analysis from the MACH-NC and MARCH collaborative groups (2017) (4)
Cost and efficacy of peripheral stem cell mobilization strategies in multiple myeloma (2020) (4)
[Locally advanced head and neck cancers: recommendations of an expert panel and perspectives for the use of TPF regimen (docetaxel, cisplatin and fluoro-uracil) as induction therapy]. (2009) (4)
Double-blind randomized phase II results comparing concurrent high-dose cisplatin chemorradiation (CRT) plus debio 1143 or placebo in high-risk patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN): A GORTEC study (2019) (4)
[New strategies to interfere with radiation response: "biomodulation" of radiation therapy]. (2005) (4)
[Advances in head and neck cancers on behalf of the French Intergroup ORL and GORTEC]. (2013) (4)
High-dose chemotherapy followed by hematological support: experience in the treatment of germ cell tumors. (1995) (4)
Pravastatin Reverses Established Radiation-Induced Cutaneous and Subcutaneous Fibrosis in Head and Neck Cancer Patients: Results of a Biology-Driven Clinical Trial, Pravacur Phase 2 (2017) (4)
Optimization of re-irradiation using deformable registration: a case study (2016) (4)
Hypoxia response pathways and radiotherapy for head and neck cancer. (2006) (4)
Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma. (1991) (4)
Randomized trials of amifostine and radiotherapy: effect on survival? (2004) (4)
Curative management of a cardiac metastasis from lung cancer revealed by an electrical storm (2019) (4)
287 Requirements for the use of an atlas-based automatic segmentation for delineation of Organs at risk (OAR) in conformal radiotherapy (CRT): quality assurance (QA) and preliminary results for 22 adult patients with primary brain tumors (2005) (4)
[Nasopharyngeal cancers, an overview]. (2014) (4)
Analysis of the treatment plan evaluation process in radiotherapy through eye tracking. (2017) (4)
Evidence of BCR-ABL1-positive progenitor spread in blood during molecular recurrence after TKI discontinuation in chronic myeloid leukemia (CML) (2020) (4)
[Building Clinical Target Volume in laryngeal cancers using knowledge about modes of invasion of each location]. (2005) (4)
Locally advanced head and neck cancer: meta-analysis of updated individual data (2001) (4)
Oncogenes and tumour suppressor genes in human cancers: clinical implications. (1992) (3)
Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey (2020) (3)
PO-091: TPExtreme randomized trial: Docetaxel-Platinum(P)-Cetuximab(C) versus 5FU-P-C in recurrent/metastatic HNSCC (2015) (3)
Can Stereotactic Body Radiotherapy Really Be Considered the Preferred Treatment in Large Hepatocellular Carcinoma? (2016) (3)
[Accelerated partial breast irradiation: bifractionated 40Gy in one week. A French pilot phase II study]. (2010) (3)
Role of Functional Imaging in Treatment Plan Optimization of Stereotactic Body Radiation Therapy for Liver Cancer (2016) (3)
Retrospective Comparison between 12-Gray and 8-Gray Total Body Irradiation (TBI) before Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Lymphoblastic Leukemia in First Complete Remission (2021) (3)
Isodose 20 Gy found as a threshold dose for radiation recall dermatitis (2019) (3)
Recent progress in the biology of multiple myeloma and future directions in the treatment. (1998) (3)
Hyperfractioned or accelerated radiotherapy in head and neck cancer: a meta‐analysis (2007) (3)
Neoadjuvant chemoradiotherapy delivered with helical tomotherapy under daily image guidance for rectal cancer patients: efficacy and safety in a large, multi-institutional series (2019) (3)
P3 The impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients. Matched-pair comparison with conventional radiotherapy (2007) (3)
What have we learned from human papillomavirus-positive tumors? Trying to connect data about biomarkers among human papillomavirus-related squamous cell carcinomas. (2010) (3)
[Usefulness of panfungal PCR for the diagnosis of fungal infection in immunocompromised patients]. (2004) (3)
Very accelerated fractionation--in response to Dr. C. C. Wang, IJROBP 32:889-890; 1995. (1995) (3)
Retrospective analysis of the impact of respiratory motion in treatment margins for frameless lung SBRT based on respiratory‐correlated CBCT data‐sets (2020) (3)
Fluorescence in situ hybridization with X and Y DNA specific probes for chimerism detection in pulmonary alveolar macrophages after human sex-mismatched allogeneic bone marrow transplantation. (1994) (3)
A phase I, open-label study (EGF 100262) of lapatinib plus chemoradiation in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN) (2007) (3)
In Regard to van Marlen et al. (2020) (3)
[Lung dose constraints for normo-fractionated radiotherapy and for stereotactic body radiation therapy]. (2017) (3)
[Towards global security in radiation oncology. Using event notification feed-back]. (2007) (3)
BEAM or BeEAM High-Dose Chemotherapy Followed By ASCT: A Single Center Comparative Analysis of Toxicity (2016) (3)
2001 ORAL Nanoscale Radiotherapy – NBTXR3 Hafnium Oxide Nanoparticles as Promising Cancer Therapy (2011) (3)
Outcome of Relapsed AML Patients Aged between 50 and 70: The ALFA Group Experience (ALFA 9801 Study). (2007) (3)
Allogeneic Stem Cell Transplantation (allo-SCT) for Chronic Lymphocytic Leukemia: a Long Term Analysis From the Societe Francaise De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC). (2009) (3)
Regulatory Effect of Recombinant Cytokines on NK Cell Differentiation from Early Marrow Precursors (1990) (3)
Can Segmentectomy Still Be Proposed As an Alternative to Lobectomy in 2016? (2017) (3)
Combined G-CSF and Plerixafor enhance hematopoietic recovery of CD34+ cells from poor mobilizer patients in NSG mice. (2020) (3)
[Preventive systemic antibiotherapy with ceftriaxone alone in neutropenic patients treated in a protected environment]. (1987) (3)
Allogeneic vs autologous stem cell transplantation according to cytogenetic and FAB features in AML patients (pts) <=45 yrs old in CRI: Results of the EORTC-GIMEMA AML-10 trial (2002) (3)
Activity and Tolerability of Azacitidine in Patients Who Relapse after Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myeloid Leukemia (AML) and Myelodysplasia (MDS): a Survey from the European Society for Blood and Marrow Transplantation (EBMT (2014) (2)
[Modulation of cellular response to ionizing radiation: towards new molecular targets?]. (1997) (2)
Enhanced Cytotoxic Activity of Ex Vivo-differentiated Human Natural Killer Cells in the Presence of HOXB4 (2014) (2)
Antiangiogenic effect and tumor growth control achieved by an MMP-inhibitor combined to radiation in vivo, targeting radio-induced MMP-2 enhancement and VEGF modulation (2004) (2)
[Squamous cell carcinoma of the hypopharynx and larynx: evidence-based care]. (2014) (2)
[Lethal aplasia after treatment with alpha-interferon of recurrent chronic myeloid leukemia following allogeneic bone marrow graft]. (1988) (2)
Abstract2779: Evaluation of Multimodality Image Registration Software and Atlas-Based Automatic Segmentation for Delineation of Organs at Risk (OAR) in the Brain in Conformal Radiotherapy (CRT) (2006) (2)
Erratum to: Assessment of the novel tubulin-binding agent EHT 6706 in combination with ionizing radiation or chemotherapy (2012) (2)
Implementation of TomoEDGE in the independent dose calculator CheckTomo (2017) (2)
Hepatobiliary scintigraphy allows the evaluation of short-term functional toxicity of liver stereotactic body radiotherapy: Results of a pilot study (2018) (2)
[First-line treatment of severe myelomas of the young subject by high-dose melphalan]. (1988) (2)
Hyperfractionated reirradiation with cetuximab for recurrent head and neck cancer: The GORTEC 2008-01 multicentric phase II study. (2018) (2)
Unrelated Allogeneic Stem Cell Transplantation for Severe Acquired Aplastic Anemia: Has Outcome Improved?. (2006) (2)
Abstract 2665: NBTXR3 hafnium oxide nanoparticle activated by ionizing radiation demonstrates marked radio-enhancement and antitumor effect via high energy deposit in human soft tissue sarcoma (2011) (2)
Randomised trial of re-irradiation combined with chemotherapy after salvage surgery in head and neck carcinoma: Carcinologic and quality of life results GETTEC and GORTEC groups (2007) (2)
1673MO The GCO-002 CACOVID-19 cohort: A French nationwide multicenter study of COVID-19 infected cancer patients and consequences on cancer management (2020) (2)
Genoidentical Donor Versus A, B, Cw, DR, DQ, HLA Allelic-Matched Unrelated Donor for Stem Cell Transplantation in Patients with Standard Risk Haematological Malignancy. (2004) (2)
Full dose re-irradiation of unresectable head and neck carcinoma (HNC): A serie of 169 patients (1998) (2)
Re-irradiation combined with chemotherapy after salvage surgery in head and neck carcinoma: A randomised trial from the Gortec and Gettec (2006) (2)
[Chimerism analysis after hematopoietic cell transplantation: Guidelines from the Francophone Society of bone marrow transplantation and cellular therapy (SFGM-TC)]. (2017) (2)
Prise en charge de l’abdomen chirurgical des patients neutropéniques : à propos de 21 observations (2001) (2)
A phase I/II randomized study of Debio1143 combined with concurrent chemoradiation therapy (CCRT) in patients with locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN). (2014) (2)
[Management of refractory ventricular tachycardia using stereotactic body radiotherapy]. (2019) (2)
Sparing healthy lung by focusing the radiation beam flow onto the emphysematous regions in the treatment of lung cancer (2017) (2)
Double Cord Blood Transplantation: Incidence, Organ Involvement and Risk Factors of Acute Graft Versus Host Disease. a Retrospective Analysis on Behalf of Eurocord, ALWP and Cqwp-EBMT (2014) (2)
[Quality criteria in radiotherapy for head and neck cancers under the aegis of Head and Neck Intergroup]. (2014) (2)
Assessment of the novel tubulin-binding agent EHT 6706 in combination with ionizing radiation or chemotherapy (2012) (2)
Concurrent Chemoradiation Therapy Versus Acceleration of Radiation Therapy With or Without Concurrent Chemotherapy in Locally Advanced Head and Neck Carcinoma (GORTEC 99-02): 7-Year Survival Data From a Phase 3 Randomized Trial and Prognostic Factors (2016) (2)
In vivo measurement of tumor cell kinetics in oropharyngeal cancer treated by radiotherapy (1992) (2)
Avelumab-cetuximab-radiotherapy versus standards of care (SoC) in patients (pts) with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Safety phase of randomized trial GORTEC 2017-01 (REACH) (2019) (2)
OC-0332: Impact of HPV on effect of chemotherapy in SCCHN : results of the GORTEC 2007-01 randomized trial (2017) (2)
A clinical distance measure for evaluating treatment plan quality difference with Pareto fronts in radiotherapy (2017) (2)
Multifaceted Role of the Transforming Growth Factor β on Effector T Cells and the Implication for CAR-T Cell Therapy (2021) (2)
Unfractionated peripheral blood stem cell autografts and CD(34+)-enriched autografts have similar long-term culture initiating capacity in multiple myeloma. (1999) (2)
[Pharmacological targeting of Mdm2: rationale and perspectives for radiosensitization]. (2011) (2)
High Dose Therapy and Autologous Stem Cell Transplantation in Marginal Zone Lymphoma : An EBMT-FIL-Gimeto Retrospective Study (2014) (2)
[Proton therapy for head and neck squamous cell carcinomas: From physics to clinic]. (2019) (2)
[Principal therapeutic uses of monoclonal antibodies in oncology]. (2002) (2)
Inhibiting bcl-2 in small cell lung cancer cell lines with oblimersen, an antisense bcl-2 oligodeoxynucleotides (ODN) is an effective strategy to enhance the efficacy of radiation in vitro and in vivo (2007) (2)
Long Term Follow-Up Shows No Clinical Benefit for CD34+ Selection of Autologous Transplants Following Myeloablative Therapy in Patients with Newly Diagnosed Myeloma : An EBMT Phase III Randomized Study. (2004) (2)
OC-0057: Meta-analysis of radiotherapy in head and neck cancers: exploratory analysis according to patient characteristics (2014) (2)
[Measurement of the kinetics of cell proliferation of cancer of the oropharynx in vivo by the incorporation of bromodeoxyuridine and flow cytometry]. (1991) (2)
Impact of Post-Remission Therapy on Survival of Older Patients with AML Treated with Intensive Chemotherapy: Results of the Multicenter ALFA-9803 Trial. (2006) (2)
A haploidentical may be a better choice than a female genoidentical donor to transplant a patient with high risk acute myelogenous leukemia in first remission (2019) (1)
Outcome Analysis of High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation in Patients with Hodgkin Lymphoma: A Francophone Society of Bone Marrow Transplantation and Cellular Therapy Study (2016) (1)
Cord Blood Transplantation after Non Myeloablative Conditioning (Minneapolis Protocol): Impact on Transplant Outcomes in 112 Adults with Hematologic Malignancy. A French Multicentric Study of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) and Eurocord. (2007) (1)
[Angiogenesis inhibitors and radiation therapy: concept and preliminary results]. (2009) (1)
[New elements in the diagnosis and the treatment of primary AL amyloid polyneuropathy and neuropathy due to POEMS syndrome]. (2011) (1)
Retrospective Study of Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome-Positive Leukemia: 25 Years' Experience at Gustave Roussy Cancer Campus. (2015) (1)
Myeloablative Versus Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Secondary Acute Myeloid Leukemia in Patients with Prior Myelodysplastic Syndrome/ Myeloproliferative Disorders: An ALWP of EBMT Study (2017) (1)
Correction to: Neoadjuvant chemoradiotherapy delivered with helical tomotherapy under daily image guidance for rectal cancer patients: efficacy and safety in a large, multi-institutional series (2019) (1)
Abstract 4891: Radiation enhances the efficacy of Bcl-2 and Bcl-XLinhibition in small cell lung cancer: A new concept of using radiation for targeted therapy through contextual oncogene addiction (2012) (1)
A metastatic relapse associated with hippocampal dose sparing after whole-brain radiotherapy (2015) (1)
Disease Status Is the Major Prognosis Factor for Allogenic Transplantation Outcome for Hodgkin Lymphoma: a Retrospective Study From the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC) (2010) (1)
Chemotherapy in locally advanced head and neck squamous cell carcinoma (HNSCC): Preliminary results of a meta-analysis using individual patient data of randomized trials (1997) (1)
[Vaccination against COVID-19 in patients with solid cancer: Review and point of view from a French oncology inter-group (CGO, TNCD, UNICANCER)]. (2021) (1)
Composite Planning to Reduce Unwanted Brain Dose in Primary CNS Lymphoma (2017) (1)
Individualized Gated Stereotactic Body Radiation Therapy for Pancreatic Cancer (2014) (1)
Allogeneic Hematopoietic Stem-Cell Transplantation for Patients with Richter's Syndrome:the SFGM-TC Experience (2018) (1)
137 Treatment of radiation enteritis with pravastatin : Role of the rho pathway on CTGF expression (2006) (1)
[The medical and surgical management of acute abdominal complications in neutropenic cancer patient: description of 21 cases]. (2001) (1)
Comparison of Reduced Intensity Conditioning - Allogeneic HCT and Autologous HCT for Elderly Patients with Acute Lymphoblastic Leukemia. an Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2020) (1)
[Angiogenesis: all a radiation oncologist should know]. (2008) (1)
PO-0899: Dosimetric evaluation of deliverable and navigated Pareto optimal plans generated with MCO (2015) (1)
[Activation of N-myc oncogene and associated genes to chemoresistance, prognostic value for neuroblastoma]. (1991) (1)
178 Radiation-induced up-regulation of CXCR4 is counteracted by association of irradiation with cidofovir (2006) (1)
[Intensity modulation in breast radiotherapy: development of an innovative field-in-field technique at Institut Gustave-Roussy]. (2011) (1)
Fludarabine or cyclophosphamide in combination with total body irradiation as myeloablative conditioning prior to allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the EBMT (2023) (1)
EP-1494: Absolute dosimetry with EBT3 Gafchromic films in a pulsed electron beam at high dose-rate (2016) (1)
[Biomodulation and radiotherapy]. (2000) (1)
Reply to D. Tural et al. (2014) (1)
PO-0604: A PET-based nomogram to predict survival in oropharyngeal cancers radiotherapy (2017) (1)
Allogeneic Hematopoietic Cell Transplantation in AML with Normal Karyotype and NPM1 Mutated FLT3-ITD Negative: A Retrospective Analysis from the Acute Leukemia Working Party of EBMT (2014) (1)
[Method of radiotherapy planning for head and neck tumors using simulated CT images and radiographic data, developed at the Gustave Roussy Institute]. (2001) (1)
PO-0722: Radiosurgery in association with immunotherapy for NSCLC brain metastases: feasibility and results (2018) (1)
Detection of an asymptomatic Covid-19 patient on CBCT-imaging (2021) (1)
[Predictive biological factors of response to radiotherapy and chemotherapy in carcinoma of the upper respiratory and digestive tracts]. (1996) (1)
EP-1179: Extraction of pulmonary emphysema structure with Myrian© software and transfer to the radiotherapy planning system (2015) (1)
514 oral ORION(r): SIMPLE AND EFFECTIVE METHOD FOR SYSTEMIC ANALYSIS OF EVENT OCCURRING IN HOSPITAL PRACTICE (2011) (1)
Allogeneic Hematopoietic Cell Transplantation for Adult Patients with ALL: Current Results and Prognostic Factors. an Analysis from Acute Leukemia Working Party of the EBMT (2015) (1)
A delivery quality assurance tool based on the actual leaf open times in tomotherapy. (2020) (1)
Comparison Of Unrelated Cord Blood (CB) and Peripheral Blood Stem Cell (PB) Transplantation In Adults With Myelodysplastic Syndrome (MDS) After Reduced Intensity Conditioning Regimen (RIC): A Collaborative Study From Eurocord and Chronic Malignancies Working Party (CMWP-EBMT) (2013) (1)
OC-0138: Apnea-like suppression of respiratory motion: first clinical evaluation (2016) (1)
Predictor of effectiveness of treatment intensification on overall survival in head and neck cancer (HNC). (2018) (1)
Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation (RIC allo-SCT) for Patients with High-Risk Multiple Myeloma (MM): A Survey from the Societe Francaise De Greffe De Moelle Et De Therapie Cellulaire. (2008) (1)
Allogeneic HCT for adults with B-cell precursor acute lymphoblastic leukemia harboring IKZF1 gene mutations. A study by the Acute Leukemia Working Party of the EBMT (2020) (1)
Hadrontherapy - macrobenefit in cancer therapy? (2012) (1)
EP-1577: Prostate cancer SBRT dose escalation to the dominant nodule/s: Phase I and immunological effects (2018) (1)
Improvement of delineation quality of organs at risk in head and neck using the consensus guidelines (2016) (1)
Optimization of Alanine Measurements for Fast and Accurate Dosimetry in FLASH Radiation Therapy. (2020) (1)
Outcomes of Cord Blood Transplantation Using Reduced Intensity Conditioning for Chronic Lymphocytic Leukemia: A Retrospective Study on Behalf of Eurocord, SFGM-TC and Cqwp-EBMT (2014) (1)
Retreatment in head and neck squamous cell carcinoma (1999) (1)
[Biological principles of chemoradiotherapy]. (1998) (1)
Induction of NSCs Quiescence and Neurogenesis Preservation in Mouse Adult Brain after FLASH Whole Brain Irradiation (2016) (1)
EP-1167: Indications for external beam radiotherapy in differentiated thyroid carcinoma: an expert consensus (2018) (1)
Absent benefit of accelerated concomitant chemoradiotherapy – Authors' reply (2012) (1)
COMPARISON OF INTENSIVE CHEMOTHERAPY AND HYPOMETHYLATING AGENTS PRIOR TO ALLOGENEIC STEM CELL TRANSPLANTATION FOR ADVANCED MDS (RAEB, RAEB-T). A STUDY OF THE MDS SUBCOMMITTEE OF THE CMWP OF EBMT (2013) (1)
Altered fractionated radiotherapy in head and neck cancer – Authors' reply (2006) (1)
Successful treatment of severe post hematopoietic stem cell transplantation bronchiolitis obliterans syndrome with lung transplantation in a patient with multi‐organ chronic graft‐versus‐host disease (2022) (1)
Analysis of the contemporary use of high-dose chemotherapy (HDCT) in germ cell tumors (GCT) in Europe: Early findings of an ongoing EBMT-sponsored study. (2014) (1)
18FDG PET CT Metabolic Parameters as Useful Prognostic Factors in Cervical Cancer Patients Treated With Chemoradiation Therapy (2015) (1)
Quantiﬁcation of Human Cytomegalovirus DNA in Bone Marrow Transplant Recipients by Real-Time PCR (2001) (1)
Long-Term Outcome Associated with Current Allogeneic Stem Cell Transplantation Procedures In Younger Adults with Adverse-Risk AML In First CR – A Real-Life Transplant Versus No-Transplant Analysis of the Acute Leukemia French Association (ALFA) (2010) (1)
Dose indicator for CyberKnife Image-Guided Radiation Therapy. (2020) (1)
Characterization of Factors Determining the Kinetics of Disease Relapse after Allogeneic Stem Cell Transplantation (allo-SCT) or Chemotherapeutic Consolidation for Acute Myeloid Leukaemia (AML) in First CR: A Survey from HOVON-SAKK and the Acute Leukaemia Working Party of the EBMT (2016) (1)
Letter by Jumeau et al Regarding Article, "Phase I/II Trial of Electrophysiology-Guided Noninvasive Cardiac Radioablation for Ventricular Tachycardia". (2019) (1)
PV-0518: Phase 1 study of Debio 1143 in combination with Concurrent Chemo-Radiotherapy in LA-SCCHN (2016) (1)
Hypoxia in Head and Neck Cancers: Clinical Relevance and Treatment (2011) (1)
2603 : Caspase-Independence of Radioinduced Cell Death in Hct116 Human Colorectal Tumor Cell Lines (2006) (1)
[Chemoradiotherapy of carcinomas of the upper aerodigestive tract]. (1998) (1)
Helical Intensity Modulated Radiation Therapy With Daily Image Guidance in the Treatment of Anal Canal Cancer (2014) (1)
917MO TOPNIVO - A safety study of nivolumab in patients with recurrent and/or metastatic platinum-refractory squamous cell carcinoma of head and neck (R/M SCCHN): Final analysis (2020) (1)
[Role of intravascular brachytherapy in the prevention of vascular restenosis after angioplasty]. (1998) (1)
Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies (2021) (1)
2179 Radiation therapy with concomitant weekly docetaxel in stages III and IV non metastatic oral cavity and oropharynx carcinomas. Results of the gortec 98-02 phase II study (1999) (1)
Prospective randomized comparison of single-dose versus hyperfractionated total-body irradiation in patients with hematologic malignancies (2001) (1)
860PIMPACT OF RESPONSE TO INDUCTION CHEMOTHERAPY IN PATIENTS WITH GERM CELL TUMORS (GCT) RECEIVING SALVAGE HIGH-DOSE CHEMOTHERAPY (HDCT): A STUDY OF THE EBMT SOLID TUMORS WORKING PARTY (STWP). (2014) (1)
[Exudative gastropathy associated with cytomegalovirus infection after allogenic bone marrow transplantation]. (1994) (1)
Higher Efficacy of TBI + Cyclophosphamide Than TBI + Fludarabine As Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia: An Analysis By the Acute Leukemia Working Party of the EBMT (2021) (1)
Isocitrate Dehydrogenase (IDH) 1 and 2 Mutation Is an Independent Predictor of Better Outcome in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Study of the ALWP of EBMT (2021) (1)
The impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancers patients. Matched-pair comparison with conventional radiotherapy (2007) (1)
Oligoclonal reconstitution after high dose therapy with PBPCT in myeloma patients: Implications for assessment of remission status (2001) (1)
[Pharmacological modulation of late radio-induced side effects]. (2011) (1)
S087 Salvage Surgery After Locoregional Failure of Concomitant Radiochemotherapy in Advanced Head and Neck Cancer (2006) (1)
High dose-per-pulse electron beam dosimetry - A saturation model for the Advanced Markus ionization chamber (2016) (1)
[Prophylactic systemic antibiotherapy with only ceftriaxone in neutropenic patients treated in a protected environment]. (1988) (1)
PO-0888 Stereotactic body radiotherapy for refractory ventricular tachycardia: clinical outcomes (2019) (1)
PD-0764 Quality of life, toxicity, and PSA control after 50 Gy SBRT to the dominant intraprostatic nodule (2021) (0)
EP-1304: Image guided intensity modulated radiotherapy for anal cancer: a multi institutional study (2016) (0)
Concurrent cisplatin and dose escalation with intensity-modulated radiotherapy (IMRT) versus conventional chemo-radiotherapy for locally advanced (LA) head and neck squamous cell carcinomas (HNSCC): GORTEC 2004-01 randomized phase III trial. (2018) (0)
EP-1216: Impact of the radiation dose on the pulmonary perfusion assessed using lung scintigraphy (2017) (0)
A415 RIC allo-SCT for Patients with High-Risk Myeloma: A Survey from the SFGM-TC (2009) (0)
Pharmacological Modulation of Platelet-derived Growth Factor Signalling with Imatinib Mesylate in a Murine Mod (2008) (0)
Reproductive Viability of Cells Following Preoperative Stereotactic Ablative Radiotherapy. (2019) (0)
136 Simultaneous normal tissue protection and increased tumor radiosensitivity : A new goal for pravastatin? (2006) (0)
PO-0703: Safety and efficacy of image guided intensity-modulated radiation therapy in the treatment of anal canal cancer (2015) (0)
A retrospective study of the allogeneic hematopoietic stem cell transplantation in Ph+ leukemia patients: the 25 years’ experience of Gustave Roussy Cancer Center (2015) (0)
OC-0086: Coronary dosimetry based on heart CT angiographies for Hodgkin lymphoma radiation therapy (2014) (0)
Prognostic Value of a New Clinically-Based Classification System in Patients with CMML Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis of the EBMT Chronic Malignancies Working Party (2018) (0)
Impact of Specific Adverse Cytogenetic Features on Outcomes after Allogeneic Hematopoietic Cell Transplantation in Myelodysplastic Syndrome with Very Poor Risk Cytogenetics: A Study from the Chronic Malignancies Working Party of EBMT (2021) (0)
2646: Combination With an Heparan-Mimetic Enhances Amifostine Protective Activity on Radiation-Induced Mucositis (2006) (0)
[Intensity modulated radiotherapy for cancers of the upper aerodigestive tract]. (2007) (0)
PO-0683: Impact of the radiation dose on hepatic perfusion evaluated using mebrofenin liver scintigraphy (2017) (0)
Dissociated responses to newer antimyeloma drugs identify a subset of refractory patients with an extremely poor prognosis. (2013) (0)
EP-1260: Helical Tomotherapy with Daily Image Guidance for Rectal Cancer patients (2017) (0)
Analysis of EGFr, VEGF and p53 in serum of head and neck squamous cell cancer (HNSCC) : Preliminary results of the GORTEC 99-02 randomized trial. (2006) (0)
[Can gene transfer be used to modify the response to radiotherapy?]. (2000) (0)
Reversion Of Lung Fibrosis In C57BL6 Mice Using Statins (2008) (0)
SP-0363 PRIMARY RT: HEAD & NECK (2012) (0)
CTGF EXPRESSION IS SENSITIVE TO CHANGES OF THE ACTIN CYTOSKELETON IN ENDOTHELIAL CELLS (2005) (0)
Role of chemotherapy (CT) in non metastatic head and neck squamous cell carcinoma (HNSCC): Results of an international meta-analysis (1999) (0)
[Cost of quality assurance in radiotherapy: human and material requirements]. (2005) (0)
Autologous versus allogeneic hematopoietic cell transplantation for older patients with acute lymphoblastic leukemia. An analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2023) (0)
OC-0486: Pravastatin reverses fibrosis in head and neck cancer patients: phase II clinical trial results (2018) (0)
Photo quiz. Dyspnea and fever in an allogeneic stem cell recipient. (2015) (0)
Persistence of Yellow Fever Immunization-Induced Antibodies in Allogeneic Hematopoietic Stem Cell Transplant Recipients. (2018) (0)
[Accelerated radiotherapy: initial results in a series of locally very advanced carcinomas of the upper respiratory and digestive tracts]. (1996) (0)
PO-0900: Where do radiation oncologists and medical physicists look when they evaluate a patient treatment plan? (2015) (0)
Intensive Care Management and Outcomes In Allogeneic Hematopoietic Stem Cell Transplantation Recipients (2013) (0)
Multi radiotherapy modalities treatment for multi targets in malignant pheochromocytoma setting - Case Report (2016) (0)
[Organ preservation in ORL oncology: myth or reality. The case for laryngeal preservation]. (1998) (0)
OC-0055: Telomere shortening in lymphocytes of Hodgkin lymphoma with coronary artery disease post treatment (2014) (0)
Treatment deintensification and symptom burden in patients with human papillomavirus‐associated head and neck cancer (2015) (0)
Allogeneic Stem Cell Transplantation in First Chronic Phase CML during the Last Decade: Retrospective Analysis of the National SFGM-TC Registry (2016) (0)
Chronic myeloid leukemia and allogeneic natural killer cells: a surprising dialogue (2006) (0)
323 POSTER Dependence on PI3K and RAS–RAF pathways drives the activity of the combination of RAD001 and RAF265, a novel inhibitor of the RAF-MAPK pathway (2008) (0)
Intravenous Once-Daily BuCy 2 With Pharmacokinetic (PK)-Guided Dose Adjustment As Conditioning Regimen For AML Patients In First Complete Remission (2013) (0)
Characterization of the immune component in the lung of KP mouse with pulmonary adenocarcinoma: from infiltrated immune cells to tertiary lymphoid structures (2016) (0)
Reduced 8-Gray Compared to Standard 12-Gray Total Body Irradiation for Allogeneic Transplantation in First Remission Acute Lymphoblastic Leukemia: A Study of the Acute Leukemia Working Party of the EBMT (2023) (0)
OC-018: GORTEC randomized trial evaluating OTD70DERM on dermatitis in head and neck cancer undergoing RT cetuximab (2015) (0)
EP-2179: Assessment of lung position reproducibility of High-Frequency Ventilation (HFV) in radiation therapy (2018) (0)
[Epidermal growth factor receptor (EGF) in head-and-neck cancers]. (2007) (0)
Concomitant versus neoadjuvant chemotherapy for patients with locally advanced head and neck cancer. Results of two individual patient data meta-analyses (2007) (0)
Electron dosimetry with Gafchromic EBT3 films: energy and dose-rate dependence (2016) (0)
Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation Transplantation and Cellular Therapy (2022) (0)
PO-0863: Intra-fraction baseline shift and margin analysis based on 4DCBCT during frameless lung stereotactic radiotherapy (2014) (0)
2360 : Randomized Trial Comparing Induction Chemotherapy With Cisplatin (P) + 5 Fluorouracil (F) Versus P + F + Docetaxel (T) Followed by Radiotherapy (RT) for Larynx Preservation. Preliminary Results of the Gortec 2000–01 Study (2006) (0)
Improved Survival for 149 First-Line Multiple Myeloma (MM) Patients (pts) Treated by Tandem Autologous (Auto)/Allogeneic (Allo) Stem Cell Transplantation (SCT) : Retrospective Study of the Société Française de Greffe de Moelle Thérapie Cellulaire (SFGM-TC). (2009) (0)
Abstract 199: Increased killing potential of ex vivo differentiated human natural killer cells in the presence of HOXB4 (2014) (0)
Hyperfractionated or accelerated radiotherapy in head and neck cancer : a fractional benefit? Commentary : a meta-analysis. Commentary (2006) (0)
PO-0793: The Advanced Markus ionization chamber is useable for measurements at ultra high dose rates (2016) (0)
The Impact of Risk‐adapted Treatment Strategy on Outcome of Patients with Acute Myeloid Leukemia Aged ≥ 60 Years after Allogeneic Stem Cell Transplant: SCT‐119 (2018) (0)
modulates their susceptibility to NK-mediated lysis c-Myc regulates expression of NKG 2 D ligands ULBP 1 / 2 / 3 in AML and (2014) (0)
[Re-irradiation and concomitant chemotherapy in unresectable locoregional recurrence of cancers of the upper respiratory-digestive tract]. (1994) (0)
Factors determining the Kinetics of Disease Relapse after Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myeloid Leukaemia (AML): a survey from the Acute Leukaemia Working Party of the EBMT (2015) (0)
Oral-Normal Tissue Damage 2 Reversion Of Lung Fibrosis In C 57 BL 6 Mice Using Statins (2008) (0)
Safety and Efficacy of Image Guided Intensity Modulated Radiation Therapy in the Treatment of Anal Canal Cancer (2015) (0)
Evidence of massive leukemic progenitor expansion in blood during molecular recurrence after TKI discontinuation in chronic myeloid leukemia (CML) (2019) (0)
The Insulin-Like Growth Factor 1 Receptor: A Target for Cancer Treatment (2007) (0)
Intraprostatic Boost Using High-dose-rate Brachytherapy (HDR-BT) According to Gross Tumor Volume (GTV) Location for Prostate Cancer: A Dosimetric Feasibility Study (2012) (0)
Contrasting Factors Determine the Kinetics of Disease Relapse after Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myeloid Leukaemia (AML): a Survey from the Acute Leukaemia Working Party of the EBMT (2014) (0)
Inhibition of radiation-induced invasiveness and endothelial sustain by an MMP-inhibitor through interaction with radiation-enhanced MMP-system and VEGF release (2004) (0)
45 speaker UPDATE OF META-ANALYSES AND EBM LEVEL 1 ON: CONCOMITANT AND INDUCTION CHEMOTHERAPY (2011) (0)
Total body irradiation versus busulfan based intermediate intensity conditioning for stem cell transplantation in ALL patients >45 years-a registry-based study by the Acute Leukemia Working Party of the EBMT. (2023) (0)
Triage Scoring System Based on Early Post-Transplant Complications for Patients with Myelodysplastic Syndrome Requiring ICU after Allo-HCT: An SFGM-TC Study (2016) (0)
PO-0784: Contemporary esophageal cancer management by chemo radiation: survey of French radiation oncologists (2018) (0)
SP-0103: Defining the need for systemic treatment, e.g. which agents and when (2013) (0)
Nasopharyngeal cancers, an overview on behalf of the French Intergroupe ORL/GORTEC (2014) (0)
Single dose versus hyperfractionated total body irradiation: Update of the randomized study and analysis of prognostic factors (1998) (0)
Prognostic Relevance of pS2 Status With Steroid Receptor Status and in Association Proliferative Activity in Node-negative Breast Cancer (1992) (0)
EP-1225: Treatment outcomes of 382 patients treated with upfront exclusive radiosurgery for brain metastases (2018) (0)
PO-0705: Could acute toxicity predict tumor regression rate in rectal cancer patients undergoing neoadjuvant treatment? (2015) (0)
[Salvage therapy of relapsing or refractory malignant lymphoma with non-myelotoxic combined chemotherapy. Results of combination of cisplatin, bleomycin, methyl-GAG and prednisolone (Cis-BMP)]. (1995) (0)
QOL for Advanced Squamous Cell Carcinoma of the Head and Neck: Results of a Phase III Randomized Trial of Tirapazamine, Cisplatin, and Radiation vs. Cisplatin and Radiation (TROG 02.02) (2009) (0)
Allogeneic Hematopoietic Stem Cell Transplantation Offers Similar Outcome after Myeloablative and Sequential Conditioning Regimen in Patients with Primary Refractory or Relapsed Acute Myeloid Leukemia: A Study from the Societe Francaise De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC) (2015) (0)
Possibilities for using monoclonal antibodies in oncology (2002) (0)
Does a Change in IPSS-R between Diagnosis and Transplant Have an Impact on Transplant Outcome in Patients with MDS? a Retrospective Analysis from the EBMT Chronic Malignancies Working Party (2020) (0)
Non T–Cell Depleted Haploidentical Versus Matched Sibling Donor Hematopoietic Stem Cell Transplantation in Adult Patients with Acute Lymphoblastic Leukemia in Remission: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2021) (0)
PO-50: Role of The Cxcl12 Axis in The Resistance of Hpv-Related Tumors to Therapy (2012) (0)
OC-0272: Twice daily reirradiation with cetuximab vs once daily chemoRT after surgery in head and neck cancer (2018) (0)
Correction: Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey (2021) (0)
Chronic gvhd is increased after allo blood cell transplantation but is associated with a reduction of relapse rate: Results of a randomized study (2000) (0)
132 The micro-environment triggered fibrogenic differentiation in human mesenchyman stem cells (2006) (0)
SU-E-T-279: Towards a Personalized Cardiovascular Dosimetry in Radiation Therapy. (2013) (0)
Atlas-based automatic segmentation (ABAS) of head structures in conformal radiation therapy (CRT): atlas development and preliminary results in clinical context (2007) (0)
751 Larynx preservation: What is new in radiotherapy? (2003) (0)
Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia Following Total Body Irradiation- the Effect of Anti- Thymocyte Globulin on Transplant Outcome: ALWP of the EBMT Study (2019) (0)
Real Life Analysis of Brentuximab Vedotin (BV) Use As Consolidation Therapy in Patients with Hodgkin's Lymphoma (HL) with High Risk of Relapse after Autologous Stem Cell Transplantation (ASCT). a Retrospective Analysis of the EBMT Lymphoma Working Party (2022) (0)
Mise au point sur les indications du G-CSF pégylé (2009) (0)
Symposium: European Head and Neck Society (EHNS)S12. Non surgical approaches (2009) (0)
Legionellosis after hematopoietic stem cell transplantation (2021) (0)
Donor Lymphocyte Infusions After Allogeneic Transplantation: A Single Center Experience (2019) (0)
Very Accelerated Radiotherapy (RT) Versus Concomitant Chemo-Radiotherapy (Ct-Rt) In Locally Advanced Head And Neck Cancer: Long Term Results From 2 Phases III GORTEC Randomized Trials (2011) (0)
Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP (2022) (0)
TRANSPLANTATION Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantation Group of Bone Transplantation (2015) (0)
PD-0577: Impact of respiratory-correlated reconstruction algorithms in the choice of margins in 4D IGRT (2013) (0)
Relapse risk score after allogeneic stem cell transplantation for MDS patients. An EBMT study from the MDS subcommittee of Chronic Malignancies Working Party (CMWP) (2016) (0)
213: Radiosensitizing effect of a RasGAP derived peptide on cell survival in human cancer cells in vitro and in vivo (2012) (0)
Protective activity on radiation-induced mucositis and effect on tumor growth of a dextran-derivative (2007) (0)
EP-1306: Helical Tomotherapy with daily image guided radiotherapy for neoadjuvant treatment of rectal cancer (2016) (0)
ALLOGENEIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA WITH NORMAL CYTOGENETICS (CN-AML): OUTCOME, RISK FACTORS AND ROLE OF MOLECULAR SUBGROUPS IN 1006 PATIENTS - A REPORT FROM THE ACUTE LEUKEMIA WORKING PARTY OF EBMT (2014) (0)
EP-1650: Use of composite plan with dose effective tool to optimize lung SBRT in re-irradiation setting. Case study (2015) (0)
Gene alterations and response to drugs (1993) (0)
Nasopharyngeal cancers, an overview on behalf of the French Intergroupe ORL/GORTEC (2014) (0)
[What is the future of the children after therapeutic irradiation of their mother during their pregnancy?]. (2008) (0)
UPDATE OF META-ANALYSES AND EBM LEVEL 1 ON: CONCOMI- TANT AND INDUCTION CHEMOTHERAPY (2011) (0)
Aberrant Repertoire and Deficient Proliferation of TCR γδ T Cells in Myelodysplastic Syndromes (MDS). (2006) (0)
Very Good Response and Overall Survival after Allogeneic Stem Cell Transplantation in Patients with Systemic Light Chain Amyloidosis; Results of a Non-Interventional Study By the Plasma Cell Disorder Subcommittee of the Chronic Malignancy Working Party of the EBMT (2015) (0)
Abstract #2481: Enhancement of radiation response by the Aurora kinase inhibitor CYC116 in Ras mutant and p53-deficient cancer cells (2009) (0)
PO-0889 IMPACT OF THE PATIENT SET-UP IN RADIOTHERAPY FOR BREAST CANCER: A PROSPECTIVE DOSIMETRIC STUDY (2012) (0)
CT-282 Case Report: Successful Management of Severe Veno-Occlusive Disease after Allogeneic Stem Cell Transplantation Using a Transjugular Intrahepatic Portosystemic Shunt. (2022) (0)
A prospective phase I/IIa trial to evaluate the safety and efficacy of GTA002, an off-the-shelf, ex vivo-cultured allogeneic NK cell preparation in patients with acute myeloid leukemia in complete morphological remission who have measurable residual disease. (2021) (0)
Enhancement of Radiation Response in p53-deficient Cancer Cells In vivo using Different Schedules of Radiation and AZD1152, an Aurora B Kinase Inhibitor (2008) (0)
Percussion Assisted Radiation Therapy (PART): A Unique Innovative, Noninvasive Approach to Control Respiratory Motion, Improve Imaging, and Radiation Therapy for Lung Cancer (2015) (0)
Allogeneic stem cell transplantation (allo-SCT) from a HLA identical sibling for CR1 AML pts aged above 55 years old after a reduced intensity conditioning: A retrospective study from the Société Française de Greffe de Moelle et de thérapie cellulaire (SFGsm-TC) (2006) (0)
EP-1259: Modern Intensity Modulated Radiotherapy with Daily Image Guidance for Anal Cancer Patients (2017) (0)
Quality Assurance (QA) of Randomized Phase 2 GORTEC Trial 2014-04 of Stereotactic Irradiation in Patients With Oligometastatic Squamous Cell Carcinomas of the Head and Neck (2016) (0)
P165 Chest-MRI under non invasive high frequency ventilation: a new promising technique (2017) (0)
493 speaker CLINICAL ONCOLOGY IN EUROPE 2011 AND BEYOND (2011) (0)
[Individual patient data meta-analyses of randomized trials for the treatment of non-metastatic head and neck squamous cell carcinomas: Principles, results and perspectives]. (2015) (0)
Improved Post-Transplant Outcomes in Recent Years for AML Patients with Intermediate Karyotype, FLT3-ITD and Wild Type NPM1: A Report from the EBMT Acute Leukemia Working Party (2022) (0)
Bortezomib As Salvage Treatment for Multiple Myeloma Relapsing after Allogeneic Haematopoietic Stem Cell Transplantation: Efficacy, Tolerance and Modulation of Graft Versus Host Disease: A Study of the French Society for Stem Cell Transplantation and Cell Therapies (SFGM-TC) (2014) (0)
non-T-cell- depleted bone marrow transplantation frequent survival of residual recipient multipotent progenitors after Highly sensitive polymerase chain reaction methods show the (2011) (0)
[Chemoradiation for oesophageal cancer: A critical review of the literature]. (2019) (0)
Treosulfan Conditioning for Allogeneic Transplantation in Multiple Myeloma – Improved Overall Survival in first line Hematopoietic Stem Cell Transplantation (2019) (0)
Dual Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2 Inhibition in Squamous Cell Carcinoma of the Head and Neck; Is the Jury Still Out? Reply (2016) (0)
P107 Dosimetric evaluation of the feasibility of an intraprostatic boost according to gross-tumor-volumes (GTVs) location for prostate cancer patients treated with combined external beam radiotherapy (EBRT) and high-dose-rate brachytherapy (HDR-BT) (2012) (0)
Impact of Pre-Graft Ruxolitinib on Post-Transplantation Outcome in Myelofibrosis Patients (2021) (0)
Antiviral agent in combination with radiotherapy for the treatment of cancer. (1999) (0)
ATG2B/Gskip in De Novo Acute Myeloid Leukemia (AML): High Prevalence of Germline Predisposition in French West Indies and Potential Role of Overexpression in Acquired AML (2018) (0)
Carotid Dose Sparing in Definitive Irradiation of Early-Stage Glottic Cancer Using Helical Tomotherapy–Based Image-Guided Intensity Modulated Radiation Therapy (2014) (0)
45 Tumor cell kinetics in head and neck squamous cell carcinoma (HNSCC) results of a multivariate analysis (1995) (0)
Validation of the Transplant Conditioning Intensity (TCI) Score for Allogeneic Hematopoietic Cell Transplantation (2022) (0)
Oral cavity squamous cell carcinoma in patients aged 80 or older: Risk factors, treatment, and outcome. (2009) (0)
No statistical impact of intra-tumoral overexpression of EGFR, VEGF and p53 on the overall survival in head and neck squamous cell cancer (HNSCC): Preliminary results of the GORTEC 99–02 randomized trial (2007) (0)
A radiation recall phenomenon induced by aromatase inhibitors (2020) (0)
[Oncogenic factors of metastatic dissemination in neuroblastoma]. (1998) (0)
SP-24: Antiviral Approaches to Optimize the Efficacy of Radiotherapy for HPV Related Tumors (2012) (0)
Effects of the Radio-Therapeutic Treatment of ENT Cancers on Quality of Life, the ORCO National Observatory (2005) (0)
[Proposal for the delineation of postoperative primary clinical target volumes in ethmoid cancers]. (2021) (0)
PO-0737: Postoperative radiotherapy in endometrial cancer: the Lausanne experience in 201 consecutive patients (2013) (0)
SECOND ALLOGENEIC STEM CELL TRANSPLANTATION: A MORTALITY ANALYSIS (2020) (0)
399 P53 serum antibodies in head and neck SCC (1995) (0)
Esthesioneuroblastomas: Bicentric Review of Clinical Features, Multimodal Treatment, and Long-term Outcome (2012) (0)
EP-1205: Spine SABR with simultaneous integrated boost using Cyberknife®: Clinical outcomes (2018) (0)
PO-0718: 18-FDG PET/CT parameters to predict survival and recurrence in cervical cancer (2017) (0)
Acute myeloid leukemia Prognostic signi fi cance of recurring chromosomal abnormalities in transplanted patients with acute myeloid leukemia (2019) (0)
Allogeneic Hematopoietic Stem Cell Transplant in Elderly Patients Using Reduce Intensity Conditioning Regimen: A Single Centre Experience: RES‐099 (2017) (0)
Oc-0507 How Many Chemotherapy Cycles During Chemoradiotherapy for Head and Neck Carcinoma? A Gortec Trial (2012) (0)
Outcomes After Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) In 163 Pediatric Patients (<18 years old): A Retrospective Study On Behalf Of The SFGM-TC (2013) (0)
transplantation: long-term results of a randomized study Chronic graft-versus-host disease after allogeneic blood stem cell (2013) (0)
EP-2201: Stereotactic arrhythmia radio-ablation using ICD electrode tracking by Cyberknife® (2018) (0)
Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms: A retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation (2023) (0)
Post-Transplantation Cyclophosphamide for Gvhd Prophylaxis in Related and Unrelated Allogeneic Hematopoietic Cell Transplantation: Study from the SFGM-TC Registry (2021) (0)
CloB2A2 Reduced-Intensity Conditioning (RIC) Regimen Prior to Allogeneic Stem Cell Transplantation Provides Significant Better Survival Compared to FB2A2 RIC Regimen in Adults with Acute Myeloid Leukemia (AML): A Study on Behalf of the SFGM-TC (2015) (0)
Serotonin Targeting Using Common Antidepressants Induces Rapid Recovery of Cytopenia (2019) (0)
Updated Analysis of Allogeneic HSCT after RIC for Hematological Malignancies from the Société Française de Greffe de Moelle Osseuse et de Thérapie Cellulaire (SFGM-TC) Registry. (2007) (0)
Allogeneic Stem Cell Transplantation (allo-SCT) for Chronic Myelomonocytic Leukemia (CMML): Prognostic Factors for Survival. A Report From the Societe Francaise De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC), (2011) (0)
Survival Improvement in Therapy Related Myeloid Neosplasm ? a Single Center Analysis of 428 Patients (2016) (0)
11:14: Botulinum Toxin for Radiation-Induced Pain and Trismus (2007) (0)
155: Cardiac toxicity induced by radiotherapy. Role of the GEF, Epac, in hypertrophy and amyloidosis but not in fibrosis (2014) (0)
High dose melphalan with or without autologous bone marrow transplantation in high risk myelomas (1988) (0)
[Radiotherapy. Radiobiological aspects, principal secondary effects]. (2001) (0)
First line chemotherapy for patients with multiple myeloma with vad regimen followed by consolidation with high-dose chemoradiotherapy with peripheral stem cells autograft (PSCA): the experience of IGR center (1994) (0)
[Radiotherapy and targeted therapies in head and neck carcinomas and NSCLC]. (2009) (0)
Assessment of Mobilization Cost for Multiple Myeloma Using 2 Different Mobilization Strategies: High-Dose Cyclophosphamide Versus Plerixafor. on Behalf of IFM (2016) (0)
SP-0290: More than one century after the serendipitous discovery of X-rays, there is still a bright future for radiation oncology … (2017) (0)
Short Telomeres Combined with Low Telomerase Activity Are Associated with a Longer Survival in Patients with Acute Myeloid Leukemia. (2007) (0)
P-277: Carfilzomib, lenalidomide and dexamethasone followed by a second autologous hematopoietic cell transplantation is an effective strategy in first-relapsed multiple myeloma (2022) (0)
An imbalance in competing mortality favouring Debio 1143 - Authors' reply. (2020) (0)
The role of apoptosis in radiation response (2001) (0)
PO-147: The ELAN program: Customised treatment of SCCHN elderly patients according to geriatric assessment (2017) (0)
Debio-1143. Inhibitor of apoptosis protein (IAP) antagonist, Cancer therapy (2017) (0)
Redefining 'state of the art' in head and neck cancer. (2005) (0)
2003 ORAL Perfusion and Permeability Study in High Grade Glioma Patients: Implications on Outcome and Importance of Steroids Uptake Before Radiotherapy (2011) (0)
116 R1507, a human monoclonal antibody targeting IGF-1R (insulin like growth factor receptor) is effective alone and sensitizes small cell lung cancer cell lines to chemotherapy and radiation in vitro (2010) (0)
Chest-MRI under non invasive high frequency ventilation: a new promising technique (2017) (0)
Autologous Stem Cell Transplantation (ASCT) for Patients Aged 60 Years or Older with Classical Hodgkin Lymphoma : A Retrospective Analysis from the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC) (2014) (0)
Response to Spartalis et al. (2018) (0)
[Oropharyngeal cancer]. (2010) (0)
Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation (0)
135 An heparan-mimetic protects mice from radiation-induced mucositis (2006) (0)
Treosulfan Conditioning for Allogeneic Transplantation in Multiple Myeloma Improved Overall Survival in Upfront Hematopoietic Stem Cell Transplantation — a Large Retrospective Study By the Chronic Malignancies Working Party of the EBMT (2018) (0)
65 The contribution of the Gustave Roussy Institute in translational radiation oncology (2006) (0)
Expression, and Synapse Formation Modulation of NKG2D Ligands, GM1 Response to Imatinib Mesylate Involves Targets to NK Cell-Mediated Lysis in The Decreased Susceptibility of Bcr/Abl (2005) (0)
Defining the Prognostic Implications of Recurring Cytogenetic Aberrations and FLT3-ITD in Acute Myeloid Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation: On Behalf of the ALWP of the EBMT (2019) (0)
Post-Remission Treatment with Autologous or Allogeneic Bone Marrow Transplantation or Intensive Chemotherapy in Younger AML Patients: Long-Term Follow-up Results of the EORTC/Gimema AML-8A Study (2016) (0)
Tandem Autologous/Allogeneic Stem Cell Transplantation for Multiple myeloma: Long-Term Outcome of a Retrospective Study (2008) (0)
320 Predictive assays: A useful tool? (1995) (0)
Could Acute Toxicity Predict Tumor Regression Rate in Rectal Cancer Patients Undergoing Neoadjuvant Treatment (2015) (0)
TOPNIVO: A safety study of nivolumab in patients with recurrent and/or metastatic platinum-refractory squamous cell carcinoma of the head and neck (R/M SCCHN): First results on behalf of the UNICANCER Head&Neck Group and the GORTEC. (2018) (0)
212: The SMAC-mimetic Debio 1143 efficiently enhanced radiotherapy in head and neck squamous cell carcinoma models (2014) (0)
Real-world use of defibrotide for veno-occlusive disease/sinusoidal obstruction syndrome: the DEFIFrance Registry Study (2022) (0)
Antithymocyte Globulins (ATG) As Part Of The Myeloablative Conditioning (MAC) Regimen Can Reduce The Risk Of Severe Graft-Vs.-Host Disease (GVHD) After Allogeneic Stem Cell Transplantation (allo-SCT) From Matched-Unrelated Donors (MUD) [A SFGM-TC Study] (2009) (0)
P17 - Clinical spectrum, causes and evolution of disabling neuropathies in patients with hematopoietic stem cell transplantation on a 20 years period (2015) (0)
Optimization of Reirradiation Using Deformable Registration (2015) (0)
Risk Factors Influencing Transplant Outcomes of Adults with Acute Lymphoblastic Leukemia in First Complete Remission: A Retrospective Analysis from the ALWP of the EBMT (2022) (0)
Infusion of Umbilical Cord Blood-Derived Natural Killer Cells in Immune-Deficient Mice for the Treatment of Resistant Acute Myeloid Leukaemia (2016) (0)
Reply to N.F. Saba and S.J. Wong. (2016) (0)
Parotid Gland Sparing With Intensity Modulated Radiation in Nasopharyngeal and Oropharyngeal Tumors: Experience of the French Group “STIC 2002 - RCMI ORL” (2007) (0)
An antiviral agent in combination with radiotherapy for use in the treatment of cancer (1999) (0)
EP-1648: A comparison of 6 planning RT techniques for breast treatments (2016) (0)
567 speaker ANTIVIRAL APPROACHES TO TREAT HPV RELATED TUMORS : THE INSTITUTE GUSTAVE ROUSSY EXPERIENCE FROM PRE-CLINICAL DATA TO CLINICAL TRIALS (2011) (0)
Are E6 and E7 the key modulators of radiosensitivity in HPV 16 and 18 carcinoma cell lines (2008) (0)
Dyspnea and Fever in an Allogeneic Stem Cell Recipient (2015) (0)
[Virus and human oncogenesis]. (1994) (0)
Antithymocyte Globulins (ATG) as Part of the Myeloablative Conditioning (MAC) Regimen Can Reduce the Risk of Severe Graft-Vs.-Host Disease (GVHD) after Allogeneic Stem Cell Transplantation (allo-SCT) from Matched-Unrelated Donors (MUD). (2008) (0)
Evaluation in-vitro et in-vivo de l’association de la radiotherapie avec le metastat™, inhibiteur des metalloproteinases matricielles (MMP), dans le modele de melanome B16 utilisant l’echo-Doppler couleur (EDC) (2004) (0)
EP-1380: Characteristics and potential clinical use of the chemical dosimeter Methyl Viologen (2015) (0)
Treatment outcome in patients (pts) with loco-regional relapse (LRR) of undifferentiated carcinoma of nasopharyngeal type (UCNT) (1999) (0)
Possibilities of gene therapy and radiotherapy (1997) (0)
Reduced-Intensity Conditioning (RIC) Regimen Followed by Allogeneic Stem Cell Transplantation (alloSCT) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLCL). A Retrospective Study from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC) Registry. (2006) (0)
Allogeneic Stem Cell Transplantation For Acute Myeloid Leukemia With Normal Cytogenetics (CN-AML): Outcome, Risk Factors and Role Of Molecular Subgroups In 752 Patients – A Report From The Acute Leukemia Working Party Of EBMT (2013) (0)
EP-1216: Changes in preoperative 18FDG-PET/CT after neoadjuvant treatments and pathological response in rectal cancer (2015) (0)
270 Potential interest in integrating functional MRI (fMRI) in 3D RT planning for grade 2 unfavorable and grade 3 gliomas: first results with 10 patients (2005) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Jean‐henri Bourhis?

Jean‐henri Bourhis is affiliated with the following schools:

University of Lausanne
Institute of Cancer Research
Paris-Saclay University
University of Melbourne
University of Birmingham

Jean‐henri Bourhis's Academic­Influence.com Rankings

Jean‐henri Bourhis's Degrees

Similar Degrees You Can Earn

Why Is Jean‐henri Bourhis Influential?

Jean‐henri Bourhis's Published Works

Published Works

What Schools Are Affiliated With Jean‐henri Bourhis?

Jean‐henri Bourhis's AcademicInfluence.com Rankings